FGFR3
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | Y24 | Sugiyama | SHTN1 KIAA1598 | sDEEKQLQLITsLKEQAIGEyEDLRAENQKTKEKCDKIRQE |
| A1L429 | Y10 | Sugiyama | GAGE12B; GAGE12C; GAGE12D; GAGE12E | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| A1L429 | Y9 | Sugiyama | GAGE12B; GAGE12C; GAGE12D; GAGE12E | ____________MSWRGRsTyyWPRPRRYVQPPEMIGPMRP |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A6NDE8 | Y10 | Sugiyama | GAGE12H | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| A6NDE8 | Y9 | Sugiyama | GAGE12H | ____________MSWRGRsTyyWPRPRRYVQPPEMIGPMRP |
| A6NER3 | Y10 | Sugiyama | GAGE12J | ___________MSWRGRsTyyWPRPRPYVQPPEMIGPMRPE |
| A6NER3 | Y9 | Sugiyama | GAGE12J | ____________MSWRGRsTyyWPRPRPYVQPPEMIGPMRP |
| O00115 | Y53 | Sugiyama | DNASE2 DNASE2A DNL2 | YKLPALRGSGEAAQRGLQYKyLDEssGGWRDGRALINsPEG |
| O00116 | Y645 | Sugiyama | AGPS AAG5 | QWLKESIsDVGFGMLKSVKEyVDPNNIFGNRNLL_______ |
| O00233 | Y41 | Sugiyama | PSMD9 | SDVQELMRRKEEIEAQIKANyDVLEsQKGIGMNEPLVDCEG |
| O00299 | Y233 | Sugiyama | CLIC1 G6 NCC27 | AyAREEFAstCPDDEEIELAyEQVAKALK____________ |
| O00401 | Y256 | Sugiyama | WASL | FDMCGIsEAQLKDRETSKVIyDFIEKTGGVEAVKNELRRQA |
| O00469 | Y444 | Sugiyama | PLOD2 | LWSNFWGALSPDGYYARsEDyVDIVQGNRVGVWNVPYMANV |
| O00488 | Y97 | Sugiyama | ZNF593 ZT86 | KTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVPPRRL |
| O00625 | Y131 | Sugiyama | PIR | AHGLQLWVNLRSSEKMVEPQyQELKSEEIPKPSKDGVTVAV |
| O14639 | Y383 | Sugiyama | ABLIM1 ABLIM KIAA0059 LIMAB1 | sIPGsPGHtIyAKVDNEILDyKDLAAIPKVKAIYDIERPDL |
| O14818 | Y145 | Sugiyama | PSMA7 HSPC | RPFGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGA |
| O14818 | Y153 | Sugiyama | PSMA7 HSPC | IVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFLE |
| O14950 | Y143 | Sugiyama | MYL12B MRLC2 MYLC2B | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14974 | Y911 | Sugiyama | PPP1R12A MBS MYPT1 | ETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDSTD |
| O14979 | Y167 | Sugiyama | HNRNPDL HNRPDL JKTBP | DGKMFIGGLSWDTsKKDLtEyLSRFGEVVDCtIKTDPVTGR |
| O15371 | Y50 | Sugiyama | EIF3D EIF3S7 | yQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQYA |
| O43143 | Y13 | Sugiyama | DHX15 DBP1 DDX15 | ________MSKRHRLDLGEDyPsGKKRAGTDGKDRDRDRDR |
| O43164 | Y63 | Sugiyama | PJA2 KIAA0438 RNF131 | VSFKPCMTRHERSLGRAGDDyEVLELDDVPKENssGssPLD |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43390 | Y376 | Sugiyama | HNRNPR HNRPR | ILEKSFSEFGKLERVKKLKDyAFVHFEDRGAAVKAMDEMNG |
| O43390 | Y434 | Sugiyama | HNRNPR HNRPR | KKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGG |
| O43390 | Y436 | Sugiyama | HNRNPR HNRPR | RKERQAARQAsRstAyEDyyyHPPPRMPPPIRGRGRGGGRG |
| O43707 | Y234 | Sugiyama | ACTN4 | KLRKDDPVTNLNNAFEVAEKyLDIPKMLDAEDIVNtARPDE |
| O43707 | Y878 | Sugiyama | ACTN4 | DKNFITAEELRRELPPDQAEyCIARMAPyQGPDAVPGALDy |
| O43823 | Y311 | Sugiyama | AKAP8 AKAP95 | RGFDRFGPDGTGRKRKQFQLyEEPDtKLARVDsEGDFsEND |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O43852 | Y129 | Sugiyama | CALU | VERQWKGHDLNEDGLVsWEEyKNATYGYVLDDPDPDDGFNY |
| O43852 | Y185 | Sugiyama | CALU | KDGDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNAD |
| O43852 | Y187 | Sugiyama | CALU | GDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNADGF |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O43865 | Y28 | Sugiyama | AHCYL1 DCAL IRBIT XPVKONA | PLPGVGEELKQAKEIEDAEKysFMATVTKAPKKQIQFADDM |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60361 | Y37 | Sugiyama | NME2P1 | GFRLVAMKFLPASEEHLKQHyIDLKDRPFFPGLVKYMNSGP |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60506 | Y373 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ILEKAFsQFGKLERVKKLKDyAFIHFDERDGAVKAMEEMNG |
| O60506 | Y614 | Sugiyama | SYNCRIP HNRPQ NSAP1 | PLQGGDHSGNYGYKSENQEFyQDTFGQQWK___________ |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60739 | Y30 | Sugiyama | EIF1B | FDPFADATKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| O60814 | Y38 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| O60814 | Y41 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| O60814 | Y43 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| O60828 | Y209 | Sugiyama | PQBP1 NPW38 JM26 | KSKKAVSRKDEELDPMDPSsysDAPRGTWstGLPKRNEAKT |
| O75116 | Y936 | Sugiyama | ROCK2 KIAA0619 | EITLTKADSEQLARsIAEEQysDLEKEKIMKELEIKEMMAR |
| O75190 | Y4 | Sugiyama | DNAJB6 HSJ2 MRJ MSJ1 | _________________MVDyyEVLGVQRHAsPEDIKKAYR |
| O75190 | Y5 | Sugiyama | DNAJB6 HSJ2 MRJ MSJ1 | ________________MVDyyEVLGVQRHAsPEDIKKAYRK |
| O75190 | Y53 | Sugiyama | DNAJB6 HSJ2 MRJ MSJ1 | DKNPENKEEAERKFKQVAEAyEVLSDAKKRDIYDKYGKEGL |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75347 | Y94 | Sugiyama | TBCA | AyLDLQRILENEKDLEEAEEyKEARLVLDsVKLEA______ |
| O75348 | Y47 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | KRKNRRLKQAKEEAQAEIEQyRLQREKEFKAKEAAALGsRG |
| O75369 | Y902 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | VQFNsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLV |
| O75369 | Y904 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | FNsPLPGDAVKDLDIIDNyDysHtVKYtPtQQGNMQVLVTY |
| O75475 | Y18 | Sugiyama | PSIP1 DFS70 LEDGF PSIP2 | ___MTRDFKPGDLIFAKMKGyPHWPARVDEVPDGAVKPPTN |
| O75874 | Y391 | Sugiyama | IDH1 PICD | FMTKDLAACIKGLPNVQRsDyLNTFEFMDKLGENLKIKLAQ |
| O76087 | Y10 | Sugiyama | GAGE7 GAGE12I GAGE7B | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| O76087 | Y9 | Sugiyama | GAGE7 GAGE12I GAGE7B | ____________MSWRGRsTyyWPRPRRYVQPPEMIGPMRP |
| O94906 | Y105 | Sugiyama | PRPF6 C20orf14 | AGSLFSSGPYEKDDEEADAIyAALDKRMDERRKERREQREK |
| O94919 | Y134 | Sugiyama | ENDOD1 KIAA0830 | EAEAITSVNSLGSKQALNtDyLDsDyQRGQLYPFSLSSDVQ |
| O95218 | Y114 | Sugiyama | ZRANB2 ZIS ZNF265 | AKLEERtGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKY |
| O95297 | Y263 | Sugiyama | MPZL1 PZR UNQ849/PRO1787 | QLDHsGGHHSDKINKSEsVVyADIRKN______________ |
| O95347 | Y938 | Sugiyama | SMC2 CAPE SMC2L1 PRO0324 | SKHKREAEDGAAKVSKMLKDyDWINAERHLFGQPNSAYDFK |
| O95359 | S2270 | Sugiyama | TACC2 | sGGQEDsPAKGLSVRLEFDysEDKSSWDNQQENPPPTKKIG |
| O95433 | Y322 | Sugiyama | AHSA1 C14orf3 HSPC322 | MEGRGIPAPEEERTRQGWQRyyFEGIKQTFGYGARLF____ |
| O95433 | Y323 | Sugiyama | AHSA1 C14orf3 HSPC322 | EGRGIPAPEEERTRQGWQRyyFEGIKQTFGYGARLF_____ |
| O95881 | Y137 | Sugiyama | TXNDC12 TLP19 UNQ713/PRO1376 | FLDPSGKVHPEIINENGNPsyKyFyVsAEQVVQGMKEAQER |
| O95926 | Y210 | Sugiyama | SYF2 CBPIN GCIPIP | IEKRDKYSRRRPYNDDADIDyINERNAKFNKKAERFYGKYT |
| O96019 | Y69 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | DGsTLMEIDGDKGKQGGPtyyIDtNALRVPRENMEAIsPLK |
| P00338 | Y10 | Sugiyama | LDHA PIG19 | ___________MAtLKDQLIyNLLKEEQtPQNKITVVGVGA |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00505 | Y96 | Sugiyama | GOT2 KYAT4 | VLPSVRKAEAQIAAKNLDKEyLPIGGLAEFCKASAELALGE |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00558 | Y196 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MVGVNLPQKAGGFLMKKELNyFAKALEsPERPFLAILGGAK |
| P00966 | Y163 | Sugiyama | ASS1 ASS | APWRMPEFYNRFKGRNDLMEyAKQHGIPIPVtPKNPWSMDE |
| P04080 | Y97 | Sugiyama | CSTB CST6 STFB | NKPLtLsNyQTNKAKHDELtyF___________________ |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05997 | S1308 | Sugiyama | COL5A2 | SKKHPARTCDDLKLCHSAKQsGEyWIDPNQGSVEDAIKVYC |
| P06733 | S268 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyP |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y287 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | PsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDDWGAWQKF |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06899 | Y38 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSK |
| P06899 | Y41 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P06899 | Y43 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07237 | Y99 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | LAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPKEytAG |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07384 | Y42 | Sugiyama | CAPN1 CANPL1 PIG30 | RARELGLGRHENAIKyLGQDyEQLRVRCLQSGTLFRDEAFP |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07437 | Y51 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | DPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPG |
| P07737 | Y129 | Sugiyama | PFN1 | tLVLLMGKEGVHGGLINKKCyEMAsHLRRsQY_________ |
| P07814 | Y754 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | ERPtPsLNNNCttsEDsLVLyNRVAVQGDVVRELKAKKAPK |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07858 | Y244 | Sugiyama | CTSB CPSB | HYGYNSYSVSNSEKDIMAEIyKNGPVEGAFSVYSDFLLYKS |
| P07900 | Y160 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPM |
| P07900 | Y197 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | GEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIGyP |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y438 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KKCLELFtELAEDKENyKKFyEQFSKNIKLGIHEDsQNRKK |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | Y155 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | SAYLVAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPI |
| P08238 | Y192 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y430 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KKCLELFsELAEDKENyKKFyEAFSKNLKLGIHEDstNRRR |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08238 | Y512 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EQVANsAFVERVRKRGFEVVyMtEPIDEyCVQQLKEFDGKs |
| P08238 | Y520 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | VERVRKRGFEVVyMtEPIDEyCVQQLKEFDGKsLVsVtKEG |
| P08238 | Y619 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | TANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVEtLR |
| P08621 | Y146 | Sugiyama | SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1 | yGPIKRIHMVYSKRsGKPRGyAFIEyEHERDMHSAYKHADG |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P08758 | Y129 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | VLtEIIAsRtPEELRAIKQVyEEEyGssLEDDVVGDTSGYY |
| P08758 | Y133 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | IIAsRtPEELRAIKQVyEEEyGssLEDDVVGDTSGYYQRML |
| P08865 | Y156 | Sugiyama | RPSA LAMBR LAMR1 | EAsyVNLPtIALCNTDSPLRyVDIAIPCNNKGAHSVGLMWW |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09234 | Y12 | Sugiyama | SNRPC | _________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHKE |
| P09234 | Y8 | Sugiyama | SNRPC | _____________MPKFyCDyCDtyLtHDsPsVRKTHCSGR |
| P09496 | Y147 | Sugiyama | CLTA | NSRKQEAEWKEKAIKELEEWyARQDEQLQKTKANNRVADEA |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P09972 | Y358 | Sugiyama | ALDOC ALDC | AAQGKYEGSGEDGGAAAQsLyIANHAY______________ |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CL80 | Y10 | Sugiyama | GAGE12F | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| P0CL80 | Y9 | Sugiyama | GAGE12F | ____________MSWRGRsTyyWPRPRRYVQPPEMIGPMRP |
| P0DSO3 | Y10 | Sugiyama | GAGE4 | ___________MSWRGRsTyyWPRPRRYVQPPEMIGPMRPE |
| P0DSO3 | Y9 | Sugiyama | GAGE4 | ____________MSWRGRsTyyWPRPRRYVQPPEMIGPMRP |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P10809 | Y227 | Sugiyama | HSPD1 HSP60 | LNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLs |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | S432 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VLIKRNtTIPTKQtQtFttysDNQPGVLIQVyEGERAMTKD |
| P11142 | Y149 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIAEAyLGKtVTNAVVtVPAyFNDsQRQAtKDAGtIAGLNV |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11362 | S602 | Sugiyama | FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR | EyCyNPsHNPEEQLSSKDLVsCAyQVARGMEYLASKKCIHR |
| P11362 | Y605 | Sugiyama | FGFR1 BFGFR CEK FGFBR FLG FLT2 HBGFR | yNPsHNPEEQLSSKDLVsCAyQVARGMEYLASKKCIHRDLA |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P11940 | Y291 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | ERQTELKRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLR |
| P11940 | Y297 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLRKEFsPF |
| P12277 | S129 | Sugiyama | CKB CKBB | DLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPHCsRG |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P12814 | Y215 | Sugiyama | ACTN1 | KLRKDDPLTNLNTAFDVAEKyLDIPKMLDAEDIVGtARPDE |
| P12814 | Y842 | Sugiyama | ACTN1 | DTDTADQVMASFKILAGDKNyITMDELRRELPPDQAEyCIA |
| P12814 | Y859 | Sugiyama | ACTN1 | DKNyITMDELRRELPPDQAEyCIARMAPYTGPDSVPGALDY |
| P13073 | Y38 | Sugiyama | COX4I1 COX4 | SVCVRAHESVVKsEDFsLPAyMDRRDHPLPEVAHVKHLSAS |
| P13639 | Y634 | Sugiyama | EEF2 EF2 | AEDIDKGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGP |
| P13639 | Y639 | Sugiyama | EEF2 EF2 | KGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGPDGTGP |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13667 | T449 | Sugiyama | PDIA4 ERP70 ERP72 | AATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLsE |
| P13667 | Y137 | Sugiyama | PDIA4 ERP70 ERP72 | VAKIDAtsAsVLAsRFDVsGyPtIKILKKGQAVDyEGsRtQ |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P14618 | Y370 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | NAVLDGADCIMLSGEtAKGDyPLEAVRMQHLIAREAEAAIy |
| P14625 | Y429 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IKLYVRRVFITDDFHDMMPKyLNFVKGVVDsDDLPLNVsRE |
| P14625 | Y527 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | AKLLRFQssHHPtDItsLDQyVERMKEKQDKIyFMAGsSRK |
| P14625 | Y539 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDItsLDQyVERMKEKQDKIyFMAGsSRKEAEssPFVERLL |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P14854 | Y57 | Sugiyama | COX6B1 COX6B | FHRCQKAMTAKGGDIsVCEWyQRVYQsLCPtsWVTDWDEQR |
| P14866 | T282 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | TLKIEYAKPTRLNVFKNDQDtWDyTNPNLsGQGDPGsNPNK |
| P15880 | Y248 | Sugiyama | RPS2 RPS4 | GCtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQE |
| P15880 | Y250 | Sugiyama | RPS2 RPS4 | tAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEFt |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17676 | Y137 | Sugiyama | CEBPB TCF5 PP9092 | FLSDLFSDDYGGKNCKKPAEyGyVsLGRLGAAKGALHPGCF |
| P17676 | Y139 | Sugiyama | CEBPB TCF5 PP9092 | SDLFSDDYGGKNCKKPAEyGyVsLGRLGAAKGALHPGCFAP |
| P17812 | Y473 | Sugiyama | CTPS1 CTPS | RRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVWKKCLE |
| P17844 | Y59 | Sugiyama | DDX5 G17P1 HELR HLR1 | EKLVKKKWNLDELPKFEKNFyQEHPDLARRtAQEVETYRRS |
| P17980 | Y185 | Sugiyama | PSMC3 TBP1 | PtEyDsRVKAMEVDERPtEQysDIGGLDKQIQELVEAIVLP |
| P17980 | Y381 | Sugiyama | PSMC3 TBP1 | ARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQCKAVCV |
| P17987 | Y545 | Sugiyama | TCP1 CCT1 CCTA | LRIDDLIKLHPESKDDKHGsyEDAVHsGALND_________ |
| P18124 | Y155 | Sugiyama | RPL7 | IVEPYIAWGYPNLKsVNELIyKRGYGKINKKRIALtDNALI |
| P18615 | Y133 | Sugiyama | NELFE RD RDBP | sIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEA |
| P18615 | Y170 | Sugiyama | NELFE RD RDBP | GEEAEGPGAGDGPPRsFDWGyEERSGAHSsAsPPRsRSRDR |
| P18615 | Y367 | Sugiyama | NELFE RD RDBP | SLAVQNsPKGCHRDKRTQIVysDDVyKENLVDGF_______ |
| P18615 | Y372 | Sugiyama | NELFE RD RDBP | NsPKGCHRDKRTQIVysDDVyKENLVDGF____________ |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18621 | Y4 | Sugiyama | RPL17 | _________________MVRysLDPENPtKsCKSRGSNLRV |
| P18669 | S137 | Sugiyama | PGAM1 PGAMA CDABP0006 | RsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLK |
| P18669 | Y119 | Sugiyama | PGAM1 PGAMA CDABP0006 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P19105 | Y142 | Sugiyama | MYL12A MLCB MRLC3 RLC | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19338 | Y351 | Sugiyama | NCL | FAKNDLAVVDVRIGMTRKFGyVDFEsAEDLEKALELtGLKV |
| P19338 | Y433 | Sugiyama | NCL | FEDAAEIRLVSKDGKSKGIAyIEFKTEADAEKTFEEKQGtE |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P20618 | S151 | Sugiyama | PSMB1 PSC5 | PYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASA |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P20618 | Y158 | Sugiyama | PSMB1 PSC5 | IGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLD |
| P21802 | Y616 | Sugiyama | FGFR2 BEK KGFR KSAM | EQMTFKDLVSCTyQLARGMEyLASQKCIHRDLAARNVLVTE |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22392 | Y52 | Sugiyama | NME2 NM23B | GFRLVAMKFLRAsEEHLKQHyIDLKDRPFFPGLVKYMNSGP |
| P22607 | S444 | Sugiyama | FGFR3 JTK4 | SLESNASMSSNTPLVRIARLssGEGPtLANVSELELPADPK |
| P22607 | S445 | Sugiyama | FGFR3 JTK4 | LESNASMSSNTPLVRIARLssGEGPtLANVSELELPADPKW |
| P22607 | S596 | Sugiyama | FGFR3 JTK4 | DySFDTCKPPEEQLTFKDLVsCAyQVARGMEyLASQKCIHR |
| P22607 | T450 | Sugiyama | FGFR3 JTK4 | SMSSNTPLVRIARLssGEGPtLANVSELELPADPKWELSRA |
| P22607 | Y577 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | FGFR3 JTK4 | YAAKGNLREFLRARRPPGLDySFDTCKPPEEQLTFKDLVsC |
| P22607 | Y599 | Sugiyama | FGFR3 JTK4 | FDTCKPPEEQLTFKDLVsCAyQVARGMEyLASQKCIHRDLA |
| P22607 | Y607 | Sugiyama | FGFR3 JTK4 | EQLTFKDLVsCAyQVARGMEyLASQKCIHRDLAARNVLVTE |
| P22607 | Y647 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | FGFR3 JTK4 | EDNVMKIADFGLARDVHNLDyyKKTTNGRLPVKWMAPEALF |
| P22607 | Y648 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | FGFR3 JTK4 | DNVMKIADFGLARDVHNLDyyKKTTNGRLPVKWMAPEALFD |
| P22607 | Y724 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | FGFR3 JTK4 | FKLLKEGHRMDKPANCTHDLyMIMRECWHAAPSQRPTFKQL |
| P22607 | Y760 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | FGFR3 JTK4 | TFKQLVEDLDRVLTVTSTDEyLDLSAPFEQysPGGQDTPSS |
| P22607 | Y770 | GPS6|SIGNOR|ELM|iPTMNet|EPSD | FGFR3 JTK4 | RVLTVTSTDEyLDLSAPFEQysPGGQDTPSSSSSGDDSVFA |
| P23246 | Y488 | Sugiyama | SFPQ PSF | PMYQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQV |
| P23246 | Y490 | Sugiyama | SFPQ PSF | YQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEK |
| P23396 | S35 | Sugiyama | RPS3 OK/SW-cl.26 | GIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATRT |
| P23396 | Y34 | Sugiyama | RPS3 OK/SW-cl.26 | DGIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATR |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23434 | Y164 | Sugiyama | GCSH | LIKMtLsNPsELDELMsEEAyEKYIKSIEE___________ |
| P23526 | Y165 | Sugiyama | AHCY SAHH | QLLPGIRGIsEEtTTGVHNLyKMMANGILKVPAINVNDsVt |
| P23526 | Y193 | Sugiyama | AHCY SAHH | LKVPAINVNDsVtKsKFDNLyGCRESLIDGIKRATDVMIAG |
| P23527 | Y38 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSK |
| P23527 | Y41 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P23527 | Y43 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y68 | Sugiyama | CFL1 CFL | ILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAt |
| P23528 | Y82 | Sugiyama | CFL1 CFL | QtVDDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFI |
| P23528 | Y85 | Sugiyama | CFL1 CFL | DDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWA |
| P23588 | Y211 | Sugiyama | EIF4B | DsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDRYDsD |
| P23588 | Y593 | Sugiyama | EIF4B | APEPKKPEENPASKFssASKyAALsVDGEDENEGEDyAE__ |
| P23588 | Y609 | Sugiyama | EIF4B | sASKyAALsVDGEDENEGEDyAE__________________ |
| P24534 | Y18 | Sugiyama | EEF1B2 EEF1B EF1B | ___MGFGDLKsPAGLQVLNDyLADKSYIEGYVPsQADVAVF |
| P25205 | Y19 | Sugiyama | MCM3 | __MAGtVVLDDVELREAQRDyLDFLDDEEDQGIyQsKVREL |
| P25205 | Y32 | Sugiyama | MCM3 | LREAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVN |
| P25208 | Y58 | Sugiyama | NFYB HAP3 | SMNDHEDTNGSKESFREQDIyLPIANVARIMKNAIPQTGKI |
| P25786 | Y6 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______________MFRNQyDNDVtVWsPQGRIHQIEYAM |
| P26196 | Y469 | Sugiyama | DDX6 HLR2 RCK | IEEQLGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP______ |
| P26196 | Y473 | Sugiyama | DDX6 HLR2 RCK | LGTEIKPIPsNIDKSLyVAEyHsEPVEDEKP__________ |
| P26599 | Y127 | Sugiyama | PTBP1 PTB | ANTMVNYYTSVTPVLRGQPIyIQFsNHKELKtDSSPNQARA |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27540 | Y561 | Sugiyama | ARNT BHLHE2 | PLEKSDGLFAQDRDPRFsEIyHNINADQSKGISSSTVPATQ |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27797 | Y109 | Sugiyama | CALR CRTC | QTLVVQFTVKHEQNIDCGGGyVKLFPNSLDQTDMHGDSEYN |
| P27816 | Y47 | Sugiyama | MAP4 | AtLEAEAFDDVVGETVGKTDyIPLLDVDEKtGNsESKKKPC |
| P28062 | Y184 | Sugiyama | PSMB8 LMP7 PSMB5i RING10 Y2 | GMGLSMGSMICGWDKKGPGLyyVDEHGTRLSGNMFSTGSGN |
| P28062 | Y185 | Sugiyama | PSMB8 LMP7 PSMB5i RING10 Y2 | MGLSMGSMICGWDKKGPGLyyVDEHGTRLSGNMFSTGSGNT |
| P28715 | Y144 | Sugiyama | ERCC5 ERCM2 XPG XPGC | RSKRDEALPSLTQVRRENDLyVLPPLQEEEKHssEEEDEKE |
| P29353 | Y427 | Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | T147 | Sugiyama | EEF1D EF1D | PQtQHVsPMRQVEPPAKKPAtPAEDDEDDDIDLFGsDNEEE |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30040 | Y202 | Sugiyama | ERP29 C12orf8 ERP28 | KQGQDNLSSVKETQKKWAEQyLKIMGKILDQGEDFPAsEMT |
| P30043 | S202 | Sugiyama | BLVRB FLR SCAN | GHFMLRCLttDEyDGHstyPsHQyQ________________ |
| P30043 | Y200 | Sugiyama | BLVRB FLR SCAN | DLGHFMLRCLttDEyDGHstyPsHQyQ______________ |
| P30043 | Y205 | Sugiyama | BLVRB FLR SCAN | MLRCLttDEyDGHstyPsHQyQ___________________ |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30086 | Y106 | Sugiyama | PEBP1 PBP PEBP | HFLVVNMKGNDIssGtVLsDyVGsGPPKGtGLHRyVWLVyE |
| P30086 | Y120 | Sugiyama | PEBP1 PBP PEBP | GtVLsDyVGsGPPKGtGLHRyVWLVyEQDRPLKCDEPILsN |
| P30086 | Y125 | Sugiyama | PEBP1 PBP PEBP | DyVGsGPPKGtGLHRyVWLVyEQDRPLKCDEPILsNRsGDH |
| P30086 | Y169 | Sugiyama | PEBP1 PBP PEBP | FKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK__ |
| P30086 | Y176 | Sugiyama | PEBP1 PBP PEBP | KKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK_________ |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y100 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAyDGPRt |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y264 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | CPHMTEDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVM |
| P30101 | Y265 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | PHMTEDNKDLIQGKDLLIAyyDVDyEKNAKGSNYWRNRVMM |
| P30101 | Y356 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | FVMQEEFsRDGKALERFLQDyFDGNLKRyLKsEPIPESNDG |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P30622 | Y108 | Sugiyama | CLIP1 CYLN1 RSN | AGIVLDEPIGKNDGSVAGVRyFQCEPLKGIFTRPSKLTRKV |
| P31153 | Y235 | Sugiyama | MAT2A AMS2 MATA2 | LDEMRDALKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGP |
| P31153 | Y242 | Sugiyama | MAT2A AMS2 MATA2 | LKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLt |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | Y151 | Sugiyama | YWHAB | LsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLG |
| P31946 | Y21 | Sugiyama | YWHAB | MTMDKsELVQKAKLAEQAERyDDMAAAMKAVtEQGHELsNE |
| P31946 | Y213 | Sugiyama | YWHAB | LAKTAFDEAIAELDtLNEEsyKDstLIMQLLRDNLtLWtSE |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y151 | Sugiyama | SFN HME1 | LAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIRLG |
| P31947 | Y19 | Sugiyama | SFN HME1 | __MERASLIQKAKLAEQAERyEDMAAFMKGAVEKGEELsCE |
| P31947 | Y213 | Sugiyama | SFN HME1 | LAKTtFDEAMADLHtLsEDsyKDstLIMQLLRDNLtLWTAD |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P31948 | Y41 | Sugiyama | STIP1 | DDALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDG |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32929 | S61 | Sugiyama | CTH | ISLSTTFKQGAPGQHsGFEysRsGNPTRNCLEKAVAALDGA |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33121 | Y693 | Sugiyama | ACSL1 FACL1 FACL2 LACS LACS1 LACS2 | TMKAKRPELRNYFRSQIDDLyStIKV_______________ |
| P33176 | Y516 | Sugiyama | KIF5B KNS KNS1 | EELAVNyDQKSQEVEDKTKEyELLSDELNQKsATLAsIDAE |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P33316 | Y227 | Sugiyama | DUT | EKFEVKKGDRIAQLICERIFyPEIEEVQALDDtERGsGGFG |
| P33778 | Y38 | Sugiyama | H2BC3 H2BFF HIST1H2BB | AITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSK |
| P33778 | Y41 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMG |
| P33778 | Y43 | Sugiyama | H2BC3 H2BFF HIST1H2BB | QKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISSKAMGIM |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P34932 | Y597 | Sugiyama | HSPA4 APG2 HSPH2 | VDLPIENQLLWQIDREMLNLyIENEGKMIMQDKLEKERNDA |
| P34932 | Y624 | Sugiyama | HSPA4 APG2 HSPH2 | MIMQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDD |
| P34932 | Y626 | Sugiyama | HSPA4 APG2 HSPH2 | MQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDDRN |
| P35222 | Y142 | EPSD|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | VQRLAEPSQMLKHAVVNLINyQDDAELATRAIPELTKLLND |
| P35268 | Y114 | Sugiyama | RPL22 | NNLRDWLRVVANSKESYELRyFQINQDEEEEEDED______ |
| P36578 | Y52 | Sugiyama | RPL4 RPL1 | IRPDIVNFVHTNLRKNNRQPyAVsELAGHQtsAEsWGtGRA |
| P36871 | Y476 | Sugiyama | PGM1 | GKQFSANDKVYtVEKADNFEysDPVDGsIsRNQGLRLIFTD |
| P37108 | Y27 | Sugiyama | SRP14 | EQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGtVE |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P38646 | Y196 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | EtAENyLGHtAKNAVItVPAyFNDsQRQAtKDAGQIsGLNV |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P40261 | Y11 | Sugiyama | NNMT | __________MESGFTSKDTyLSHFNPRDYLEKYYKFGSRH |
| P40429 | Y149 | Sugiyama | RPL13A | LKPTRKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYR |
| P40763 | Y705 | SIGNOR|EPSD | STAT3 APRF | KyCRPEsQEHPEADPGsAAPyLKTKFICVtPttCsNtIDLP |
| P40926 | Y80 | Sugiyama | MDH2 | HtPGVAADLsHIEtKAAVKGyLGPEQLPDCLKGCDVVVIPA |
| P40939 | Y637 | Sugiyama | HADHA HADH | ELLTQMVSKGFLGRKSGKGFyIyQEGVKRKDLNSDMDSILA |
| P40939 | Y639 | Sugiyama | HADHA HADH | LTQMVSKGFLGRKSGKGFyIyQEGVKRKDLNSDMDSILASL |
| P41567 | Y30 | Sugiyama | EIF1 SUI1 | FDPFADAsKGDDLLPAGTEDyIHIRIQQRNGRKtLttVQGI |
| P42224 | Y701 | SIGNOR|iPTMNet|EPSD|PSP | STAT1 | YSRPKEAPEPMELDGPKGtGyIKtELIsVsEVHPSRLQttD |
| P42765 | Y198 | Sugiyama | ACAA2 | ECDKyALQSQQRWKAANDAGyFNDEMAPIEVKTKKGKQTMQ |
| P43243 | Y202 | Sugiyama | MATR3 KIAA0723 | RHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDD |
| P43490 | Y34 | Sugiyama | NAMPT PBEF PBEF1 | ATDSYKVTHYKQYPPNTSKVysyFECREKKTENSKLRKVKY |
| P45974 | Y849 | Sugiyama | USP5 ISOT | WVIYNDQKVCASEKPPKDLGyIyFyQRVAS___________ |
| P45974 | Y851 | Sugiyama | USP5 ISOT | IYNDQKVCASEKPPKDLGyIyFyQRVAS_____________ |
| P46777 | Y207 | Sugiyama | RPL5 MSTP030 | sKEFNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyI |
| P46777 | Y210 | Sugiyama | RPL5 MSTP030 | FNAEVHRKHIMGQNVADyMRyLMEEDEDAyKKQFsQyIKNs |
| P46777 | Y219 | Sugiyama | RPL5 MSTP030 | IMGQNVADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEM |
| P46777 | Y226 | Sugiyama | RPL5 MSTP030 | DyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAA |
| P46778 | Y156 | Sugiyama | RPL21 | REAHFVRTNGKEPELLEPIPyEFMA________________ |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P46940 | Y1478 | Sugiyama | IQGAP1 KIAA0051 | KIQTGLKKLTELGtVDPKNKyQELINDIARDIRNQRRYRQR |
| P47756 | Y232 | Sugiyama | CAPZB | NIGRLVEDMENKIRstLNEIyFGKTKDIVNGLRSVQTFADK |
| P47756 | Y59 | Sugiyama | CAPZB | LLSSVDQPLKIARDKVVGKDyLLCDyNRDGDSyRsPWSNKy |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49207 | Y32 | Sugiyama | RPL34 | sYNtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGR |
| P49207 | Y34 | Sugiyama | RPL34 | NtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGRLR |
| P49327 | Y2462 | Sugiyama | FASN FAS | NVMLLRAKtGGAyGEDLGADyNLsQVCDGKVsVHVIEGDHR |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P49458 | Y18 | Sugiyama | SRP9 | ___MPQYQTWEEFSRAAEKLyLADPMKARVVLKYRHsDGNL |
| P49585 | Y182 | Sugiyama | PCYT1A CTPCT PCYT1 | RIDFVAHDDIPysSAGSDDVyKHIKEAGMFAPTQRTEGIST |
| P49588 | Y690 | Sugiyama | AARS1 AARS | DCPLAAAKAIQGLRAVFDEtyPDPVRVVSIGVPVSELLDDP |
| P49753 | Y351 | Sugiyama | ACOT2 PTE2 PTE2A | GETLPPVGVNRNRIKVTKDGyADIVDVLNsPLEGPDQKSFI |
| P50502 | Y213 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | RLLGHWEEAAHDLALACKLDyDEDAsAMLKEVQPRAQKIAE |
| P50542 | Y163 | Sugiyama | PEX5 PXR1 | EFISEVTDPLSVSPARWAEEyLEQsEEKLWLGEPEGTATDR |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P50991 | Y269 | Sugiyama | CCT4 CCTD SRB | IQFCLSAPKTDMDNQIVVSDyAQMDRVLREERAYILNLVKQ |
| P51116 | Y614 | Sugiyama | FXR2 FMR1L2 | RGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLERTKPs |
| P51812 | Y488 | EPSD|PSP | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | LRyGQHPNIITLKDVyDDGKyVYVVTELMKGGELLDKILRQ |
| P51812 | Y529 | EPSD|PSP | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | KFFSEREASAVLFTITKTVEyLHAQGVVHRDLKPSNILYVD |
| P51858 | Y23 | Sugiyama | HDGF HMG1L2 | RSNRQKEYKCGDLVFAKMKGyPHWPARIDEMPEAAVKstAN |
| P52272 | Y681 | Sugiyama | HNRNPM HNRPM NAGR1 | PFDFTWKMLKDKFNECGHVLyADIKMENGKSKGCGVVKFEs |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P52597 | Y266 | Sugiyama | HNRNPF HNRPF | ySGLSDGYGFTTDLFGRDLsyCLsGMyDHRYGDsEFtVQsT |
| P52597 | Y82 | Sugiyama | HNRNPF HNRPF | GsEDDVKMALKKDRESMGHRyIEVFKSHRTEMDWVLKHsGP |
| P52655 | Y365 | Sugiyama | GTF2A1 TF2A1 | SKNKWKFHLKDGIMNLNGRDyIFSKAIGDAEW_________ |
| P53634 | Y438 | Sugiyama | CTSC CPPI | SGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIEsIAVAAt |
| P54105 | Y214 | Sugiyama | CLNS1A CLCI ICLN | QsVssQYNMAGVRtEDsIRDyEDGMEVDttPtVAGQFEDAD |
| P54105 | Y38 | Sugiyama | CLNS1A CLCI ICLN | RQQPDTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSLEY |
| P54577 | Y289 | Sugiyama | YARS1 YARS | FPLKSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDL |
| P54577 | Y292 | Sugiyama | YARS1 YARS | KSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDLKNS |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55196 | Y1230 | Sugiyama | AFDN AF6 MLLT4 | QtPPPRPEAyPIPtQtYtREyFtFPAsKsQDRMAPPQNQWP |
| P55196 | Y1497 | Sugiyama | AFDN AF6 MLLT4 | VIRELQPQQQPRTIERRDLQyItVsKEELssGDsLsPDPWK |
| P55209 | Y106 | Sugiyama | NAP1L1 NRP | VKCAQIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYE |
| P55209 | Y110 | Sugiyama | NAP1L1 NRP | QIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYEPTEE |
| P55209 | Y96 | Sugiyama | NAP1L1 NRP | RRVNALKNLQVKCAQIEAKFyEEVHDLERKyAVLyQPLFDK |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P57053 | Y38 | Sugiyama | H2BC12L H2BFS H2BS1 | AVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P57053 | Y41 | Sugiyama | H2BC12L H2BFS H2BS1 | KAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P57053 | Y43 | Sugiyama | H2BC12L H2BFS H2BS1 | QKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P58876 | Y38 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| P58876 | Y41 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P58876 | Y43 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P60484 | Y240 | SIGNOR|EPSD|PSP | PTEN MMAC1 TEP1 | LKVKIYSSNsGPtRREDKFMyFEFPQPLPVCGDIKVEFFHK |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y86 | Sugiyama | MYL6 | DFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y294 | Sugiyama | ACTB | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P60900 | Y160 | Sugiyama | PSMA6 PROS27 | LIGIDEEQGPQVYKCDPAGyyCGFKATAAGVKQtEstsFLE |
| P61024 | S9 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | ____________MSHKQIyysDKyDDEEFEyRHVMLPKDIA |
| P61024 | Y19 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | __MSHKQIyysDKyDDEEFEyRHVMLPKDIAKLVPKTHLMs |
| P61024 | Y7 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | ______________MSHKQIyysDKyDDEEFEyRHVMLPKD |
| P61024 | Y8 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | _____________MSHKQIyysDKyDDEEFEyRHVMLPKDI |
| P61081 | T176 | Sugiyama | UBE2M UBC12 | NRRLFEQNVQRSMRGGyIGstyFERCLK_____________ |
| P61081 | Y172 | Sugiyama | UBE2M UBC12 | VLQNNRRLFEQNVQRSMRGGyIGstyFERCLK_________ |
| P61158 | Y231 | Sugiyama | ACTR3 ARP3 | REVGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSK |
| P61158 | Y233 | Sugiyama | ACTR3 ARP3 | VGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSKWI |
| P61158 | Y400 | Sugiyama | ACTR3 ARP3 | GGSMLASTPEFYQVCHTKKDyEEIGPsICRHNPVFGVMs__ |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61247 | Y31 | Sugiyama | RPS3A FTE1 MFTL | KGGKKGAKKKVVDPFSKKDWyDVKAPAMFNIRNIGKTLVTR |
| P61313 | Y6 | Sugiyama | RPL15 EC45 TCBAP0781 | _______________MGAYKyIQELWRKKQSDVMRFLLRVR |
| P61353 | S39 | Sugiyama | RPL27 | SGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKVTAAMGK |
| P61353 | Y75 | Sugiyama | RPL27 | AAMGKKKIAKRSKIKSFVKVyNyNHLMPtRysVDIPLDKtV |
| P61353 | Y77 | Sugiyama | RPL27 | MGKKKIAKRSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVN |
| P61353 | Y85 | Sugiyama | RPL27 | RSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPA |
| P61586 | Y156 | Sugiyama | RHOA ARH12 ARHA RHO12 | QEPVKPEEGRDMANRIGAFGyMECsAKTKDGVREVFEMAtR |
| P61604 | Y76 | Sugiyama | HSPE1 | KGGEIQPVsVKVGDKVLLPEyGGtKVVLDDKDyFLFRDGDI |
| P61604 | Y88 | Sugiyama | HSPE1 | GDKVLLPEyGGtKVVLDDKDyFLFRDGDILGKyVD______ |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | S215 | Sugiyama | YWHAG | HLAKtAFDDAIAELDtLNEDsyKDstLIMQLLRDNLtLWts |
| P61981 | Y20 | Sugiyama | YWHAG | _MVDREQLVQKARLAEQAERyDDMAAAMKNVtELNEPLsNE |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62191 | Y184 | Sugiyama | PSMC1 | MDDTDPLVTVMKVEKAPQETyADIGGLDNQIQEIKESVELP |
| P62241 | Y117 | Sugiyama | RPS8 OK/SW-cl.83 | VKNCIVLIDStPYRQWyEsHyALPLGRKKGAKLtPEEEEIL |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y214 | Sugiyama | YWHAE | LAKAAFDDAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | Y18 | Sugiyama | RPS13 | ___MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVKEQIy |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62312 | Y72 | Sugiyama | LSM6 | VNGQLKNKyGDAFIRGNNVLyIstQKRRM____________ |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62750 | Y74 | Sugiyama | RPL23A | LRRQPKYPRKSAPRRNKLDHyAIIKFPLTTEsAMKKIEDNN |
| P62753 | Y156 | Sugiyama | RPS6 OK/SW-cl.2 | KRASRIRKLFNLsKEDDVRQyVVRKPLNKEGKKPRTKAPKI |
| P62805 | Y52 | Sugiyama | H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4C16 H4-16 HIST4H4 | KPAIRRLARRGGVKRIsGLIyEETRGVLKVFLENVIRDAVt |
| P62807 | Y38 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | AVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssK |
| P62807 | Y41 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMG |
| P62807 | Y43 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | QKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62888 | Y62 | Sugiyama | RPL30 | KAKLVILANNCPALRKsEIEyyAMLAKtGVHHysGNNIELG |
| P62888 | Y63 | Sugiyama | RPL30 | AKLVILANNCPALRKsEIEyyAMLAKtGVHHysGNNIELGt |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62910 | Y95 | Sugiyama | RPL32 PP9932 | RKFLVHNVKELEVLLMCNKsyCAEIAHNVSsKNRKAIVERA |
| P62913 | Y170 | Sugiyama | RPL11 | CIGAKHRISKEEAMRWFQQKyDGIILPGK____________ |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | Y27 | Sugiyama | FKBP1A FKBP1 FKBP12 | tIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPF |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63104 | Y19 | Sugiyama | YWHAZ | __MDKNELVQKAKLAEQAERyDDMAACMKsVtEQGAELsNE |
| P63104 | Y211 | Sugiyama | YWHAZ | LAKtAFDEAIAELDtLsEEsyKDstLIMQLLRDNLtLWtsD |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63173 | Y41 | Sugiyama | RPL38 | KSVKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLP |
| P63173 | Y43 | Sugiyama | RPL38 | VKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLPPG |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y294 | Sugiyama | ACTG1 ACTG | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | Y196 | Sugiyama | YBX1 NSEP1 YB1 | sAPEGQAQQRRPyRRRRFPPyyMRRPYGRRPQysNPPVQGE |
| P67809 | Y208 | Sugiyama | YBX1 NSEP1 YB1 | yRRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGE |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68104 | Y254 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | CILPPtRPTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKP |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P83731 | Y11 | Sugiyama | RPL24 | __________MKVELCsFsGyKIYPGHGRRYARTDGKVFQF |
| P84090 | Y22 | Sugiyama | ERH | sHTILLVQPTKRPEGRtyADyEsVNECMEGVCKMYEEHLKR |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| P98179 | Y117 | Sugiyama | RBM3 RNPL | HGRGRSYSRGGGDQGYGSGRyyDsRPGGyGyGyGRSRDYNG |
| P98179 | Y118 | Sugiyama | RBM3 RNPL | GRGRSYSRGGGDQGYGSGRyyDsRPGGyGyGyGRSRDYNGR |
| Q00169 | Y140 | Sugiyama | PITPNA PITPN | GTQENVHKLEPEAWKHVEAVyIDIADRSQVLSKDYKAEEDP |
| Q00610 | Y883 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | EARIHEGCEEPAtHNALAKIyIDsNNNPERFLRENPyyDsR |
| Q00653 | Y247 | Sugiyama | NFKB2 LYT10 | NLKISRMDKTAGSVRGGDEVyLLCDKVQKDDIEVRFYEDDE |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01105 | Y140 | Sugiyama | SET | LTRVEVtEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNE |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q01130 | Y44 | Sugiyama | SRSF2 SFRS2 | RtsPDtLRRVFEKYGRVGDVyIPRDRYTKESRGFAFVRFHD |
| Q02878 | Y115 | Sugiyama | RPL6 TXREB1 | PVGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQ |
| Q04760 | Y136 | SIGNOR|PSP | GLO1 | HNGNsDPRGFGHIGIAVPDVySACKRFEELGVKFVKKPDDG |
| Q04760 | Y49 | Sugiyama | GLO1 | DFLLQQtMLRVKDPKKSLDFyTRVLGMtLIQKCDFPIMKFS |
| Q04837 | Y73 | Sugiyama | SSBP1 SSBP | PVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRISVFRPG |
| Q04917 | Y154 | Sugiyama | YWHAH YWHA1 | LAEVASGEKKNsVVEAsEAAyKEAFEISKEQMQPTHPIRLG |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05639 | Y254 | Sugiyama | EEF1A2 EEF1AL STN | TILPPTRPTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRP |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07157 | Y1191 | Sugiyama | TJP1 ZO1 | LRPEAQPHPsAGPKPAEsKQyFEQysRsyEQVPPQGFTSRA |
| Q07666 | Y145 | Sugiyama | KHDRBS1 SAM68 | LtAEIEKIQKGDSKKDDEENyLDLFsHKNMKLKERVLIPVK |
| Q07866 | Y449 | Sugiyama | KLC1 KLC KNS2 | HAEEREECKGKQKDGTsFGEyGGWyKACKVDsPtVTTtLKN |
| Q07866 | Y453 | Sugiyama | KLC1 KLC KNS2 | REECKGKQKDGTsFGEyGGWyKACKVDsPtVTTtLKNLGAL |
| Q07955 | Y189 | Sugiyama | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | TYAVRKLDNTKFRsHEGEtAyIRVKVDGPRsPsyGRsRsRs |
| Q07960 | Y64 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | sDDsKsssPELVtHLKWDDPyyDIARHQIVEVAGDDKYGRK |
| Q08043 | Y229 | Sugiyama | ACTN3 | KLRKDDPIGNLNTAFEVAEKyLDIPKMLDAEDIVNtPKPDE |
| Q08211 | Y68 | Sugiyama | DHX9 DDX9 LKP NDH2 | MGNSTNKKDAQSNAARDFVNyLVRINEIKsEEVPAFGVAsP |
| Q08380 | Y446 | Sugiyama | LGALS3BP M2BP | RKSQLVYQSRRGPLVKYssDyFQAPSDYRYYPYQSFQTPQH |
| Q08J23 | Y51 | Sugiyama | NSUN2 SAKI TRM4 | EAGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALR |
| Q08J23 | Y52 | Sugiyama | NSUN2 SAKI TRM4 | AGWEGGyPEIVKENKLFEHyyQELKIVPEGEWGQFMDALRE |
| Q12874 | Y50 | Sugiyama | SF3A3 SAP61 | KSTLRDQINSDHRTRAMQDRyMEVSGNLRDLyDDKDGLRKE |
| Q12906 | Y579 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | VEVDGQKFQGAGSNKKVAKAyAALAALEKLFPDtPLALDAN |
| Q13069 | Y10 | Sugiyama | GAGE5 | ___________MSWRGRsTyyWPRPRRYVQPPEVIGPMRPE |
| Q13069 | Y9 | Sugiyama | GAGE5 | ____________MSWRGRsTyyWPRPRRYVQPPEVIGPMRP |
| Q13070 | Y10 | Sugiyama | GAGE6 | ___________MSWRGRsTyyWPRPRRYVQPPEVIGPMRPE |
| Q13070 | Y9 | Sugiyama | GAGE6 | ____________MSWRGRsTyyWPRPRRYVQPPEVIGPMRP |
| Q13123 | T117 | Sugiyama | IK RED RER | EKYRDRAKERRDGVNKDyEEtELISTTANyRAVGPTAEADK |
| Q13123 | Y114 | Sugiyama | IK RED RER | ELAEKYRDRAKERRDGVNKDyEEtELISTTANyRAVGPTAE |
| Q13123 | Y126 | Sugiyama | IK RED RER | RRDGVNKDyEEtELISTTANyRAVGPTAEADKSAAEKRRQL |
| Q13263 | S459 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ssQPMEVQEGyGFGsGDDPyssAEPHVsGVKRsRsGEGEVs |
| Q13263 | T514 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DLDLtADsQPPVFKVFPGsttEDyNLIVIERGAAAAATGQP |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y242 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ESCDTLTCRDCQLNAHKDHQyQFLEDAVRNQRKLLAsLVKR |
| Q13263 | Y517 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | LtADsQPPVFKVFPGsttEDyNLIVIERGAAAAATGQPGtA |
| Q13283 | T21 | Sugiyama | G3BP1 G3BP | MVMEKPsPLLVGREFVRQyytLLNQAPDMLHRFYGKNssyV |
| Q13283 | Y20 | Sugiyama | G3BP1 G3BP | _MVMEKPsPLLVGREFVRQyytLLNQAPDMLHRFYGKNssy |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13405 | Y45 | Sugiyama | MRPL49 C11orf4 NOF1 OK/SW-cl.67 | LLSQTQGPPDYPRFVEsVDEyQFVERLLPATRIPDPPKHEH |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13442 | Y17 | Sugiyama | PDAP1 HASPP28 | ____MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREE |
| Q13480 | Y627 | Sugiyama | GAB1 | NSLDGGSSPMIKPKGDKQVEyLDLDLDsGKstPPRKQKssG |
| Q13561 | Y6 | Sugiyama | DCTN2 DCTN50 | _______________MADPKyADLPGIARNEPDVYETSDLP |
| Q13561 | Y81 | Sugiyama | DCTN2 DCTN50 | RVGTKGLDFsDRIGKTKRtGyEsGEyEMLGEGLGVKETPQQ |
| Q13561 | Y86 | Sugiyama | DCTN2 DCTN50 | GLDFsDRIGKTKRtGyEsGEyEMLGEGLGVKETPQQKYQRL |
| Q13573 | Y430 | Sugiyama | SNW1 SKIIP SKIP | RLFNQSKGMDSGFAGGEDEIyNVyDQAWRGGKDMAQsIyRP |
| Q13642 | Y207 | Sugiyama | FHL1 SLIM1 | VCVTCSKKLAGQRFTAVEDQyyCVDCYKNFVAKKCAGCKNP |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q14151 | Y741 | Sugiyama | SAFB2 KIAA0138 | YEQERRPGRRPYDLDRRDDAyWPEGKRVAMEDRYRADFPRP |
| Q14152 | Y697 | Sugiyama | EIF3A EIF3S10 KIAA0139 | LEKEKKELQERLKNQEKKIDyFERAKRLEEIPLIKSAYEEQ |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14247 | Y334 | Sugiyama | CTTN EMS1 | KDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRANF |
| Q14247 | Y446 | Sugiyama | CTTN EMS1 | sFKAELsyRGPVsGtEPEPVysMEAADyREASSQQGLAYAT |
| Q14247 | Y545 | Sugiyama | CTTN EMS1 | IDDGWWRGVCKGRyGLFPANyVELRQ_______________ |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14257 | Y313 | Sugiyama | RCN2 ERC55 | DLFLtsEAtDyGRQLHDDyFyHDEL________________ |
| Q14257 | Y54 | Sugiyama | RCN2 ERC55 | ERRsDyDREALLGVQEDVDEyVKLGHEEQQKRLQAIIKKID |
| Q14568 | Y160 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERM |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14671 | Y83 | Sugiyama | PUM1 KIAA0099 PUMH1 | SPVPGSIGVAGRsQDDAMVDyFFQRQHGEQLGGGGsGGGGy |
| Q14677 | Y159 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | AQDDDRLREERKKAKKNKDKyVGVssDsVGGFRysERYDPE |
| Q14677 | Y293 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | tRHKRTANPsKtIDLGAAAHytGDKAsPDQNAstHtPQssV |
| Q15056 | Y101 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | FKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRKQ |
| Q15056 | Y86 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | sIRsVRLVRDKDTDKFKGFCyVEFDEVDsLKEALtyDGALL |
| Q15181 | Y169 | Sugiyama | PPA1 IOPPP PP | EGETDWKVIAINVDDPDAANyNDINDVKRLKPGYLEATVDW |
| Q15293 | T144 | Sugiyama | RCN1 RCN | WKDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtF |
| Q15293 | Y115 | Sugiyama | RCN1 RCN | GDGFVttEELKtWIKRVQKRyIFDNVAKVWKDYDRDKDDKI |
| Q15293 | Y147 | Sugiyama | RCN1 RCN | YDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFKKM |
| Q15293 | Y148 | Sugiyama | RCN1 RCN | DRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFKKML |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15650 | Y289 | Sugiyama | TRIP4 RQT4 | LLEFDRtsIRRtQVIDDESDyFASDSNQWLSKLERETLQKR |
| Q15785 | Y54 | Sugiyama | TOMM34 URCC3 | RALRVLQAQGssDPEEEsVLysNRAACHLKDGNCRDCIKDC |
| Q16658 | Y493 | Sugiyama | FSCN1 FAN1 HSN SNL | DHAGVLKASAEtVDPAsLWEy____________________ |
| Q16719 | S443 | Sugiyama | KYNU | VVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAET |
| Q16719 | Y441 | Sugiyama | KYNU | RGVVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsA |
| Q16719 | Y448 | Sugiyama | KYNU | RNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAETKN___ |
| Q16719 | Y47 | Sugiyama | KYNU | ERVALHLDEEDKLRHFRECFyIPKIQDLPPVDLSLVNKDEN |
| Q16778 | Y38 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssK |
| Q16778 | Y41 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q16778 | Y43 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | QKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIssKAMGIM |
| Q32MZ4 | Y597 | Sugiyama | LRRFIP1 GCF2 TRIP | KKKKsPVPVETLKDVKKELtyQNTDLsEIKEEEQVKstDRK |
| Q4VXU2 | Y291 | Sugiyama | PABPC1L C20orf119 | ERQNELKRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLR |
| Q4VXU2 | Y297 | Sugiyama | PABPC1L C20orf119 | KRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLRKEFSPY |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q58FF6 | Y167 | Sugiyama | HSP90AB4P | GEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIGCL |
| Q58FF7 | Y171 | Sugiyama | HSP90AB3P HSP90BC | GEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIGyP |
| Q58FF7 | Y492 | Sugiyama | HSP90AB3P HSP90BC | TANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIMETLR |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5JTH9 | Y1251 | Sugiyama | RRP12 KIAA0690 | AEYKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQG |
| Q5JTH9 | Y1253 | Sugiyama | RRP12 KIAA0690 | YKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQGQF |
| Q5QNW6 | Y38 | Sugiyama | H2BC18 HIST2H2BF | AVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q5QNW6 | Y41 | Sugiyama | H2BC18 HIST2H2BF | KVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q5QNW6 | Y43 | Sugiyama | H2BC18 HIST2H2BF | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q5VTE0 | Y254 | Sugiyama | EEF1A1P5 EEF1AL3 | CILPPtRPTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKP |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q5VV41 | Y216 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | KKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQEsDDDILD |
| Q6DN03 | Y38 | Sugiyama | H2BC20P HIST2H2BC | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCK |
| Q6DN03 | Y41 | Sugiyama | H2BC20P HIST2H2BC | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DN03 | Y43 | Sugiyama | H2BC20P HIST2H2BC | QKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMGIM |
| Q6DRA6 | Y38 | Sugiyama | H2BC19P HIST2H2BD | AVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCK |
| Q6DRA6 | Y41 | Sugiyama | H2BC19P HIST2H2BD | KAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMG |
| Q6DRA6 | Y43 | Sugiyama | H2BC19P HIST2H2BD | QKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWCKAMGIM |
| Q6N021 | Y1902 | SIGNOR|PSP | TET2 KIAA1546 Nbla00191 | ATTPLKNPNRNHPTRISLVFyQHKSMNEPKHGLALWEAKMA |
| Q6PKG0 | Y361 | Sugiyama | LARP1 KIAA0731 LARP | GRGRGRGRGRGRGGTRtHFDyQFGyRKFDGVEGPRtPKYMN |
| Q6PKG0 | Y365 | Sugiyama | LARP1 KIAA0731 LARP | GRGRGRGRGGTRtHFDyQFGyRKFDGVEGPRtPKYMNNITY |
| Q6PKG0 | Y633 | Sugiyama | LARP1 KIAA0731 LARP | MEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPHyM |
| Q6PKG0 | Y685 | Sugiyama | LARP1 KIAA0731 LARP | HTSRAKMSAELAKVINDGLFyyEQDLWAEKFEPEysQIKQE |
| Q6PKG0 | Y686 | Sugiyama | LARP1 KIAA0731 LARP | TSRAKMSAELAKVINDGLFyyEQDLWAEKFEPEysQIKQEV |
| Q6PKG0 | Y699 | Sugiyama | LARP1 KIAA0731 LARP | INDGLFyyEQDLWAEKFEPEysQIKQEVENFKKVNMISREQ |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6UN15 | Y453 | Sugiyama | FIP1L1 FIP1 RHE | HLPGSAPsWPSLVDTSKQWDyyARREKDRDRERDRDRERDR |
| Q6WKZ4 | Y1254 | Sugiyama | RAB11FIP1 RCP | VLKQKETISKKEFQVRELEDyIDNLLVRVMEETPNILRIPT |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q7KZF4 | S474 | Sugiyama | SND1 TDRD11 | LVSKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLH |
| Q7L804 | Y480 | Sugiyama | RAB11FIP2 KIAA0941 | LVKHKELLRRKDTHIRELEDyIDNLLVRVMEETPSILRVPY |
| Q7Z417 | S266 | Sugiyama | NUFIP2 KIAA1321 PIG1 | QQETsVPTLKQGLEtFKPDysEQKGNRVDGSKPIWKYETGP |
| Q7Z4V5 | Y18 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | ___MPHAFKPGDLVFAKMKGyPHWPARIDDIADGAVKPPPN |
| Q86SX6 | Y85 | Sugiyama | GLRX5 C14orf87 | PQCGFSNAVVQILRLHGVRDyAAyNVLDDPELRQGIKDYSN |
| Q86SX6 | Y88 | Sugiyama | GLRX5 C14orf87 | GFSNAVVQILRLHGVRDyAAyNVLDDPELRQGIKDYSNWPT |
| Q86TX2 | Y289 | Sugiyama | ACOT1 CTE1 | GETLPPVGVNRNRIKVTKDGyADIVDVLNsPLEGPDQKSFI |
| Q86U42 | Y217 | Sugiyama | PABPN1 PAB2 PABP2 | sVNRVTILCDKFSGHPKGFAyIEFSDKEsVRTSLALDEsLF |
| Q86V81 | Y250 | Sugiyama | ALYREF ALY BEF THOC4 | AGRNSKQQLsAEELDAQLDAyNARMDts_____________ |
| Q8IVM0 | Y144 | Sugiyama | CCDC50 C3orf6 | EKKRKKHFPEFPATRAyADsyyyEDGGMKPRVMKEAVSTPS |
| Q8IVM0 | Y145 | Sugiyama | CCDC50 C3orf6 | KKRKKHFPEFPATRAyADsyyyEDGGMKPRVMKEAVSTPSR |
| Q8IXH6 | Y211 | Sugiyama | TP53INP2 C20orf110 DOR PINH | RQNRARESRPRRSKNQSsFIyQPCQRQFNY___________ |
| Q8N0Y7 | S137 | Sugiyama | PGAM4 PGAM3 | RsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYESPK |
| Q8N0Y7 | Y119 | Sugiyama | PGAM4 PGAM3 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| Q8N1G4 | Y257 | Sugiyama | LRRC47 KIAA1185 | LRDKRLEKMVSGCQTRSILEyLRVGGRGGGKGKGRAEGSEK |
| Q8N257 | Y38 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | AVTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssK |
| Q8N257 | Y41 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMG |
| Q8N257 | Y43 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | QKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIssKAMGIM |
| Q8N5P1 | Y97 | Sugiyama | ZC3H8 ZC3HDC8 | sDNDICsQEsEDNFAKELQQyIQAREMANAAQPEESTKKEG |
| Q8N7H5 | Y136 | Sugiyama | PAF1 PD2 | tssKRSQQHAKVVPWMRKTEyISTEFNRYGIsNEKPEVKIG |
| Q8N7H5 | Y322 | Sugiyama | PAF1 PD2 | KASKGyEENyFFIFREGDGVyyNELETRVRLSKRRAKAGVQ |
| Q8NBS9 | Y251 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | ALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDG |
| Q8ND56 | Y455 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | RGFRGGFRGGRGGREFADFEyRKTTAFGP____________ |
| Q8NFI4 | Y213 | Sugiyama | ST13P5 FAM10A5 | RLLGHWEEAAHDLAFACKLDyDEDAsAMLKEVQPRAQKIAE |
| Q8NI22 | Y135 | Sugiyama | MCFD2 SDNSF | DELINIIDGVLRDDDKNNDGyIDyAEFAKSLQ_________ |
| Q8NI22 | Y138 | Sugiyama | MCFD2 SDNSF | INIIDGVLRDDDKNNDGyIDyAEFAKSLQ____________ |
| Q8TDD1 | Y681 | Sugiyama | DDX54 | GPNRGAKRRREEARQRDQEFyIPyRPKDFDSERGLsIsGEG |
| Q8TEW0 | S386 | Sugiyama | PARD3 PAR3 PAR3A | YEQLSQSEKNNyyssRFsPDsQyIDNRSVNSAGLHTVQRAP |
| Q8TEW0 | Y1080 | Sugiyama | PARD3 PAR3 PAR3A | QERIQAKTREFRERQARERDyAEIQDFHRTFGCDDELMYGG |
| Q8WWF6 | Y53 | Sugiyama | DNAJB3 HCG3 | DKNPENKEEAERRFKQVAEAyEVLSDAKKRDIYDRYGEAGA |
| Q8WYP5 | Y1790 | Sugiyama | AHCTF1 ELYS TMBS62 MSTP108 | QSVRKKTRKAKEISEASENIySDVRGLsQNQQIPQNsVtPR |
| Q92522 | Y48 | Sugiyama | H1-10 H1FX | AALsPsKKRKNSKKKNQPGKySQLVVEtIRRLGERNGSSLA |
| Q92882 | Y207 | Sugiyama | OSTF1 | sLLKKKQGTDAVRtLsNAEDyLDDEDsD_____________ |
| Q93052 | Y300 | Sugiyama | LPP | GLQPEPGYGYAPNQGRyyEGyyAAGPGyGGRNDsDPtyGQQ |
| Q93052 | Y301 | Sugiyama | LPP | LQPEPGYGYAPNQGRyyEGyyAAGPGyGGRNDsDPtyGQQG |
| Q93079 | Y38 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q93079 | Y41 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q93079 | Y43 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q96C19 | T84 | Sugiyama | EFHD2 SWS1 | DLNQGIGEPQsPsRRVFNPytEFKEFSRKQIKDMEKMFKQy |
| Q96C90 | Y29 | Sugiyama | PPP1R14B PLCB3N PNG | GAALAAPAPGPGsGGPGPRVyFQsPPGAAGEGPGGADDEGP |
| Q96CT7 | Y38 | Sugiyama | CCDC124 | RRAEAKAAADAKKQKELEDAyWKDDDKHVMRKEQRKEEKEK |
| Q96EU6 | Y138 | Sugiyama | RRP36 C6orf153 HSPC253 | RDPRFDDLSGEYNPEVFDKtyQFLNDIRAKEKELVKKQLKK |
| Q96HE7 | Y178 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | HDDSSDNFCEADDIQsPEAEyVDLLLNPERYTGYKGPDAWK |
| Q99459 | Y210 | Sugiyama | CDC5L KIAA0432 PCDC5RP | ELRAAGIEIQKKRKRKRGVDyNAEIPFEKKPALGFyDtsEE |
| Q99459 | Y511 | Sugiyama | CDC5L KIAA0432 PCDC5RP | EIVLPENAEKELEEREIDDtyIEDAADVDARKQAIRDAERV |
| Q99459 | Y788 | Sugiyama | CDC5L KIAA0432 PCDC5RP | ECLKEDVQRQQEREKELQHRyADLLLEKETLKSKF______ |
| Q99460 | Y950 | Sugiyama | PSMD1 | AHGPKIEEEEQEPEPPEPFEyIDD_________________ |
| Q99470 | Y187 | Sugiyama | SDF2 | GRPISGQKEVHGMAQPSQNNyWKAMEGIFMKPSELLKAEAH |
| Q99733 | Y85 | Sugiyama | NAP1L4 NAP2 | RRINALKQLQVRCAHIEAKFyEEVHDLERKyAALyQPLFDK |
| Q99733 | Y95 | Sugiyama | NAP1L4 NAP2 | VRCAHIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVE |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99848 | Y265 | Sugiyama | EBNA1BP2 EBP2 | NQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPG |
| Q99877 | Y38 | Sugiyama | H2BC15 H2BFD HIST1H2BN | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99877 | Y41 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99877 | Y43 | Sugiyama | H2BC15 H2BFD HIST1H2BN | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99879 | Y38 | Sugiyama | H2BC14 H2BFE HIST1H2BM | AINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99879 | Y41 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99879 | Y43 | Sugiyama | H2BC14 H2BFE HIST1H2BM | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99880 | Y38 | Sugiyama | H2BC13 H2BFC HIST1H2BL | AVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssK |
| Q99880 | Y41 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMG |
| Q99880 | Y43 | Sugiyama | H2BC13 H2BFC HIST1H2BL | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BRL6 | Y44 | Sugiyama | SRSF8 SFRS2B SRP46 | RtsPDsLRRVFEKYGRVGDVyIPREPHTKAPRGFAFVRFHD |
| Q9BS40 | Y20 | Sugiyama | LXN | _MEIPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQA |
| Q9BS40 | Y23 | Sugiyama | LXN | IPPTNYPASRAALVAQNyINyQQGTPHRVFEVQKVKQAsME |
| Q9BTD8 | Y424 | Sugiyama | RBM42 | FPsFLKAKVIRDKRTGKTKGyGFVSFKDPsDyVRAMREMNG |
| Q9BTD8 | Y435 | Sugiyama | RBM42 | DKRTGKTKGyGFVSFKDPsDyVRAMREMNGKYVGSRPIKLR |
| Q9BUP3 | Y62 | Sugiyama | HTATIP2 CC3 TIP30 | GLFSKVTLIGRRKLTFDEEAyKNVNQEVVDFEKLDDYASAF |
| Q9BXP5 | Y864 | Sugiyama | SRRT ARS2 ASR2 | GYPGKPRNRMVRGDPRAIVEyRDLDAPDDVDFF________ |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9BZI7 | S166 | Sugiyama | UPF3B RENT3B UPF3X | KRDTKVGtIDDDPEyRKFLEsyAtDNEKMTstPEtLLEEIE |
| Q9H1E3 | Y13 | Sugiyama | NUCKS1 NUCKS JC7 | ________MSRPVRNRKVVDysQFQEsDDADEDyGRDsGPP |
| Q9H6T3 | Y90 | Sugiyama | RPAP3 | KESSKKTREENTKNRIKsyDyEAWAKLDVDRILDELDKDDs |
| Q9H788 | Y131 | Sugiyama | SH2D4A PPP1R38 SH2A | EEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKDIWKKVAE |
| Q9H7E2 | Y452 | Sugiyama | TDRD3 | SVDYNNQKRGKREsQTSIPDyFYDRKsQTINNEAFSGIKIE |
| Q9H814 | Y152 | Sugiyama | PHAX RNUXA | TELGILGMEGTIDRsRQsEtyNyLLAKKLRKESQEHTKDLD |
| Q9H814 | Y154 | Sugiyama | PHAX RNUXA | LGILGMEGTIDRsRQsEtyNyLLAKKLRKESQEHTKDLDKE |
| Q9H814 | Y57 | Sugiyama | PHAX RNUXA | GDsAMRAFQNTAtACAPVSHyRAVESVDSSEESFSDSDDDS |
| Q9HB71 | Y165 | Sugiyama | CACYBP S100A6BP SIP PNAS-107 | VKTDTVLILCRKKVENTRWDyLtQVEKECKEKEKPsYDtEt |
| Q9HCN8 | Y81 | Sugiyama | SDF2L1 UNQ1941/PRO4424 | GSGSGQQSVtGVEAsDDANSyWRIRGGSEGGCPRGSPVRCG |
| Q9HDC5 | Y417 | Sugiyama | JPH1 JP1 | AARQECDIARAVARELsPDFyQPGPDyVKQRFQEGVDAKEN |
| Q9HDC5 | Y423 | Sugiyama | JPH1 JP1 | DIARAVARELsPDFyQPGPDyVKQRFQEGVDAKENPEEKVP |
| Q9NP61 | Y408 | Sugiyama | ARFGAP3 ARFGAP1 | ETVLKTTGYSDRPTARRKPDyEPVENTDEAQKKFGNVKAIs |
| Q9NRX4 | Y113 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | ysMAyGPAQHAISTEKIKAKyPDyEVtWANDGy________ |
| Q9NRX4 | Y52 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | RSGAPAAESKEIVRGYKWAEyHADIyDKVSGDMQKQGCDCE |
| Q9NRX4 | Y57 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | AAESKEIVRGYKWAEyHADIyDKVSGDMQKQGCDCECLGGG |
| Q9NVS9 | Y157 | Sugiyama | PNPO | NRQVRVEGPVKKLPEEEAECyFHSRPKssQIGAVVSHQSSV |
| Q9NVS9 | Y195 | Sugiyama | PNPO | SSVIPDREYLRKKNEELEQLyQDQEVPKPKSWGGYVLYPQV |
| Q9NVS9 | Y256 | Sugiyama | PNPO | LPtGDsPLGPMTHRGEEDWLyERLAP_______________ |
| Q9NWS0 | Y194 | Sugiyama | PIH1D1 NOP17 | IsQQNIRSEQRPRIQELGDLytPAPGRAESGPEKPHLNLWL |
| Q9NXW2 | Y111 | Sugiyama | DNAJB12 | TKGYTAEQVAAVKRVKQCKDyyEILGVSRGASDEDLKKAYR |
| Q9NXW2 | Y112 | Sugiyama | DNAJB12 | KGYTAEQVAAVKRVKQCKDyyEILGVSRGASDEDLKKAYRR |
| Q9NY12 | Y145 | Sugiyama | GAR1 NOLA1 | FSVKLSENMKASSFKKLQKFyIDPyKLLPLQRFLPRPPGEK |
| Q9NY12 | Y149 | Sugiyama | GAR1 NOLA1 | LSENMKASSFKKLQKFyIDPyKLLPLQRFLPRPPGEKGPPR |
| Q9P031 | Y97 | Sugiyama | CCDC59 BR22 TAP26 HSPC128 | AQTSLESQFtDRYPDNLKHLyLAEEERHRKQARKVDHPLSE |
| Q9UBL3 | Y251 | Sugiyama | ASH2L ASH2L1 | RDVFLVKEHPDPGSKDPEEDyPKFGLLDQDLSNIGPAYDNQ |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UII2 | Y58 | Sugiyama | ATP5IF1 ATPI ATPIF1 | GsIREAGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEI |
| Q9UK59 | Y533 | Sugiyama | DBR1 | LsDEHEPEQRKKIKRRNQAIyAAVDDDDDDAA_________ |
| Q9UKK9 | Y16 | Sugiyama | NUDT5 NUDIX5 HSPC115 | _____MEsQEPtEssQNGKQyIISEELIsEGKWVKLEKTTY |
| Q9UKS6 | Y206 | Sugiyama | PACSIN3 | RKLQERVERCAKEAEKTKAQyEQtLAELHRYTPRYMEDMEQ |
| Q9UKV3 | S388 | Sugiyama | ACIN1 ACINUS KIAA0670 | EEEEREIKssQGLKEKsKsPsPPRLtEDRKKAsLVALPEQt |
| Q9UKV3 | Y1086 | Sugiyama | ACIN1 ACINUS KIAA0670 | RTALHGVKWPQSNPKFLCADyAEQDELDyHRGLLVDRPsEt |
| Q9UKV3 | Y1094 | Sugiyama | ACIN1 ACINUS KIAA0670 | WPQSNPKFLCADyAEQDELDyHRGLLVDRPsEtKTEEQGIP |
| Q9UKY7 | Y244 | Sugiyama | CDV3 H41 | NRGRDEVSKNQALKLQLDNQyAVLENQKSSHSQYN______ |
| Q9UMX5 | Y65 | Sugiyama | NENF CIR2 SPUF | RLFtEEELARYGGEEEDQPIyLAVKGVVFDVtSGKEFYGRG |
| Q9UN86 | Y19 | Sugiyama | G3BP2 KIAA0660 | __MVMEKPsPLLVGREFVRQyytLLNKAPEYLHRFYGRNSS |
| Q9UN86 | Y20 | Sugiyama | G3BP2 KIAA0660 | _MVMEKPsPLLVGREFVRQyytLLNKAPEYLHRFYGRNSSY |
| Q9UNF0 | Y267 | Sugiyama | PACSIN2 | VLLEVQKHLDLSNVAGYKAIyHDLEQsIRAADAVEDLRWFR |
| Q9UNP9 | Y143 | Sugiyama | PPIE CYP33 | KAETQEGEPIAKKARSNPQVyMDIKIGNKPAGRIQMLLRSD |
| Q9UPZ9 | Y15 | SIGNOR|PSP | CILK1 ICK KIAA0936 | ______MNRYTTIRQLGDGTyGSVLLGRSIESGELIAIKKM |
| Q9Y230 | Y446 | Sugiyama | RUVBL2 INO80J TIP48 TIP49B CGI-46 | IKRVysLFLDEsRSTQYMKEyQDAFLFNELKGEtMDTS___ |
| Q9Y237 | S72 | Sugiyama | PIN4 | MEAMEKLKSGMRFNEVAAQysEDKARQGGDLGWMTRGSMVG |
| Q9Y281 | Y82 | Sugiyama | CFL2 | DTVEDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFI |
| Q9Y281 | Y85 | Sugiyama | CFL2 | EDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWA |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y3C1 | Y118 | Sugiyama | NOP16 CGI-117 HSPC111 | EAEASLPEKKGNTLSRDLIDyVRYMVENHGEDYKAMARDEK |
| Q9Y3D8 | Y31 | Sugiyama | AK6 CINAP AD-004 CGI-137 | TPGVGKTTLGKELASKSGLKyINVGDLAREEQLYDGYDEEY |
| Q9Y3E1 | Y22 | Sugiyama | HDGFL3 HDGF2 HDGFRP3 CGI-142 | ARPRPREYKAGDLVFAKMKGyPHWPARIDELPEGAVKPPAN |
| Q9Y3F4 | Y114 | Sugiyama | STRAP MAWD UNRIP | LMTLAHKHIVKtVDFtQDSNyLLtGGQDKLLRIYDLNKPEA |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
| Q9Y450 | Y56 | Sugiyama | HBS1L HBS1 KIAA1038 | TAAQFIYSRRDKPsVEPVEEyDyEDLKEssNsVsNHQLSGF |
| Q9Y450 | Y58 | Sugiyama | HBS1L HBS1 KIAA1038 | AQFIYSRRDKPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQ |
| Q9Y4H2 | Y814 | Sugiyama | IRS2 | PLRGVPGCCyssLPRSYKAPytCGGDsDQyVLMssPVGRIL |
| Q9Y4H2 | Y823 | Sugiyama | IRS2 | yssLPRSYKAPytCGGDsDQyVLMssPVGRILEEERLEPQA |
| Q9Y4H2 | Y919 | Sugiyama | IRS2 | PSLPSMHEYPLPPEPKsPGEyINIDFGEPGARLsPPAPPLL |
| Q9Y5K3 | Y182 | Sugiyama | PCYT1B CCTB | KIDFVAHDDIPysSAGSDDVyKHIKEAGMFVPTQRTEGIST |
| Q9Y5Q8 | Y393 | Sugiyama | GTF3C5 CDABP0017 | SGtsGARKPASSKYKLKDSVyIFREGALPPYRQMFYQLCDL |
| Q9Y5S9 | Y54 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KRKGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWI |
| Q9Y639 | Y216 | Sugiyama | NPTN SDFR1 SDR1 | KNASNMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKA |
| Q9Y639 | Y220 | Sugiyama | NPTN SDFR1 SDR1 | NMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKAAPDI |
| Q9Y696 | Y244 | Sugiyama | CLIC4 | AysRDEFtNtCPsDKEVEIAysDVAKRLTK___________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.089347e-10 | 9.293 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.087542e-09 | 8.964 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.830456e-09 | 8.548 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.316890e-09 | 8.635 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.254890e-09 | 8.647 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 6.130408e-09 | 8.213 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.188033e-08 | 7.925 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.790393e-08 | 7.421 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.152413e-07 | 6.938 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.262838e-07 | 6.203 | 1 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.739806e-06 | 5.427 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.026096e-05 | 4.989 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.302944e-05 | 4.885 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.836327e-05 | 4.234 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.603035e-05 | 4.180 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.337263e-05 | 4.134 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 9.758980e-05 | 4.011 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.574028e-05 | 4.019 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.044646e-04 | 3.981 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.110057e-04 | 3.955 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.113193e-04 | 3.953 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.380329e-04 | 3.860 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 2.040443e-04 | 3.690 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.904589e-04 | 3.537 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 3.508084e-04 | 3.455 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.689692e-04 | 3.433 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.375184e-04 | 3.359 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.375184e-04 | 3.359 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 6.678989e-04 | 3.175 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.678989e-04 | 3.175 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 7.412032e-04 | 3.130 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 9.441343e-04 | 3.025 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 1.301245e-03 | 2.886 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.100858e-03 | 2.958 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.326375e-03 | 2.877 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.161367e-03 | 2.935 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.247734e-03 | 2.904 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.247734e-03 | 2.904 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.247734e-03 | 2.904 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.406682e-03 | 2.852 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.408616e-03 | 2.851 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.464542e-03 | 2.834 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.464542e-03 | 2.834 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.505509e-03 | 2.822 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.679378e-03 | 2.775 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.093702e-03 | 2.679 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.093702e-03 | 2.679 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 2.093702e-03 | 2.679 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 2.114737e-03 | 2.675 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.447843e-03 | 2.611 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.829188e-03 | 2.548 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 2.829188e-03 | 2.548 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.815362e-03 | 2.550 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.815362e-03 | 2.550 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.046375e-03 | 2.516 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.053961e-03 | 2.515 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.501075e-03 | 2.456 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 3.668613e-03 | 2.435 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 3.965388e-03 | 2.402 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.141105e-03 | 2.383 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 4.609629e-03 | 2.336 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.957983e-03 | 2.305 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.131513e-03 | 2.290 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.131513e-03 | 2.290 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.649925e-03 | 2.248 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.649925e-03 | 2.248 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.649925e-03 | 2.248 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.599220e-03 | 2.252 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 5.649925e-03 | 2.248 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.835196e-03 | 2.234 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.787230e-03 | 2.168 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.787230e-03 | 2.168 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.609284e-03 | 2.180 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.156240e-03 | 2.211 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 6.787230e-03 | 2.168 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.787230e-03 | 2.168 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.833113e-03 | 2.165 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.152283e-03 | 2.146 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.099331e-02 | 1.959 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.099331e-02 | 1.959 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.099331e-02 | 1.959 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.099331e-02 | 1.959 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.099331e-02 | 1.959 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.099331e-02 | 1.959 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.099331e-02 | 1.959 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.099331e-02 | 1.959 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.099331e-02 | 1.959 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.099331e-02 | 1.959 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.099331e-02 | 1.959 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.099331e-02 | 1.959 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.099331e-02 | 1.959 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.099331e-02 | 1.959 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.099331e-02 | 1.959 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.099331e-02 | 1.959 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.099331e-02 | 1.959 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.099331e-02 | 1.959 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.099331e-02 | 1.959 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.099331e-02 | 1.959 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.099331e-02 | 1.959 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.099331e-02 | 1.959 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.099331e-02 | 1.959 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.099331e-02 | 1.959 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.099331e-02 | 1.959 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.099331e-02 | 1.959 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.099331e-02 | 1.959 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.099331e-02 | 1.959 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.099331e-02 | 1.959 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.099331e-02 | 1.959 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.099331e-02 | 1.959 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 9.343968e-03 | 2.029 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.315667e-03 | 2.080 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 9.583954e-03 | 2.018 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.095895e-02 | 1.960 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.095895e-02 | 1.960 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.075904e-02 | 1.968 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.583954e-03 | 2.018 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 9.343968e-03 | 2.029 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.736072e-03 | 2.059 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.625045e-03 | 2.118 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.019310e-03 | 2.096 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.075904e-02 | 1.968 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.154089e-03 | 2.038 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.146980e-02 | 1.940 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.168696e-02 | 1.932 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.226241e-02 | 1.911 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.244220e-02 | 1.905 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.385197e-02 | 1.858 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.322482e-02 | 1.879 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.385197e-02 | 1.858 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.385197e-02 | 1.858 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.552569e-02 | 1.809 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.463001e-02 | 1.835 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.559749e-02 | 1.807 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.564066e-02 | 1.806 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.704054e-02 | 1.769 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.704054e-02 | 1.769 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.728153e-02 | 1.762 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.728153e-02 | 1.762 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.728153e-02 | 1.762 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 1.728153e-02 | 1.762 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.728153e-02 | 1.762 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.186644e-02 | 1.660 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.911751e-02 | 1.719 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.911751e-02 | 1.719 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.103168e-02 | 1.677 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.103168e-02 | 1.677 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 2.103168e-02 | 1.677 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 2.103168e-02 | 1.677 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.755290e-02 | 1.756 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.947943e-02 | 1.710 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.911751e-02 | 1.719 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.755290e-02 | 1.756 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.038440e-02 | 1.691 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.151821e-02 | 1.667 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.853186e-02 | 1.732 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.103168e-02 | 1.677 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.947943e-02 | 1.710 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 2.151821e-02 | 1.667 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 1.927772e-02 | 1.715 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.755290e-02 | 1.756 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.062771e-02 | 1.686 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.257130e-02 | 1.646 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.257976e-02 | 1.646 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.257976e-02 | 1.646 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.257976e-02 | 1.646 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.257976e-02 | 1.646 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 2.302211e-02 | 1.638 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 2.302211e-02 | 1.638 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.508692e-02 | 1.601 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.508692e-02 | 1.601 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 2.508692e-02 | 1.601 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.508692e-02 | 1.601 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.722425e-02 | 1.565 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.722425e-02 | 1.565 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.722425e-02 | 1.565 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.736039e-02 | 1.563 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 2.736039e-02 | 1.563 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.943228e-02 | 1.531 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.170921e-02 | 1.499 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.170921e-02 | 1.499 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 3.170921e-02 | 1.499 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.201401e-02 | 1.495 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.262070e-02 | 1.487 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.262070e-02 | 1.487 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.262070e-02 | 1.487 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.262070e-02 | 1.487 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.325737e-02 | 1.364 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 4.325737e-02 | 1.364 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 4.325737e-02 | 1.364 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 4.325737e-02 | 1.364 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.325737e-02 | 1.364 | 0 | 0 |
| NTF3 activates NTRK3 signaling | R-HSA-9034013 | 4.325737e-02 | 1.364 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.325737e-02 | 1.364 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.325737e-02 | 1.364 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.325737e-02 | 1.364 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.325737e-02 | 1.364 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.325737e-02 | 1.364 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.325737e-02 | 1.364 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.325737e-02 | 1.364 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.325737e-02 | 1.364 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.325737e-02 | 1.364 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.646275e-02 | 1.438 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.646275e-02 | 1.438 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.646275e-02 | 1.438 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 4.147112e-02 | 1.382 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.473606e-02 | 1.459 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 3.610454e-02 | 1.442 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.646275e-02 | 1.438 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.967984e-02 | 1.401 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.646275e-02 | 1.438 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 4.147112e-02 | 1.382 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.473606e-02 | 1.459 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.646275e-02 | 1.438 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.000280e-02 | 1.398 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.147112e-02 | 1.382 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.335629e-02 | 1.363 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.406670e-02 | 1.356 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.406670e-02 | 1.356 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 4.406670e-02 | 1.356 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 4.672105e-02 | 1.330 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.803000e-02 | 1.318 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.943257e-02 | 1.306 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.943257e-02 | 1.306 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 5.000292e-02 | 1.301 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 5.219970e-02 | 1.282 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.220818e-02 | 1.282 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.294063e-02 | 1.276 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.377774e-02 | 1.269 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.377774e-02 | 1.269 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.377774e-02 | 1.269 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 5.377774e-02 | 1.269 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.377774e-02 | 1.269 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 5.789469e-02 | 1.237 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 5.789469e-02 | 1.237 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.808345e-02 | 1.236 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.081956e-02 | 1.216 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.081956e-02 | 1.216 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.081956e-02 | 1.216 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.102912e-02 | 1.214 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 6.418307e-02 | 1.193 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 6.418307e-02 | 1.193 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 6.418307e-02 | 1.193 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 7.447461e-02 | 1.128 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 7.447461e-02 | 1.128 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 7.447461e-02 | 1.128 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 8.465360e-02 | 1.072 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 8.465360e-02 | 1.072 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 8.465360e-02 | 1.072 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 8.465360e-02 | 1.072 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 9.472126e-02 | 1.024 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 9.472126e-02 | 1.024 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 9.472126e-02 | 1.024 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 1.046788e-01 | 0.980 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.046788e-01 | 0.980 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 1.046788e-01 | 0.980 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.046788e-01 | 0.980 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 1.046788e-01 | 0.980 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.300114e-02 | 1.137 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.921023e-02 | 1.050 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.042364e-01 | 0.982 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.891038e-02 | 1.051 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.046788e-01 | 0.980 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 8.465360e-02 | 1.072 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.596611e-02 | 1.018 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 9.472126e-02 | 1.024 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 1.046788e-01 | 0.980 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.936179e-02 | 1.100 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.616010e-02 | 1.118 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.260489e-02 | 1.083 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.465360e-02 | 1.072 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.046788e-01 | 0.980 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 7.447461e-02 | 1.128 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 8.465360e-02 | 1.072 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 6.988624e-02 | 1.156 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 7.447461e-02 | 1.128 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 7.447461e-02 | 1.128 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 1.046788e-01 | 0.980 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.028629e-01 | 0.988 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.625940e-02 | 1.064 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 8.465360e-02 | 1.072 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.289213e-02 | 1.137 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.256996e-02 | 1.034 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.988624e-02 | 1.156 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.260489e-02 | 1.083 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.921023e-02 | 1.050 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.071559e-01 | 0.970 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.092707e-01 | 0.961 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.145274e-01 | 0.941 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.145274e-01 | 0.941 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.145274e-01 | 0.941 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 1.145274e-01 | 0.941 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.145274e-01 | 0.941 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.145274e-01 | 0.941 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.242683e-01 | 0.906 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.339027e-01 | 0.873 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.339027e-01 | 0.873 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.339027e-01 | 0.873 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.434316e-01 | 0.843 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.434316e-01 | 0.843 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.434316e-01 | 0.843 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.434316e-01 | 0.843 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.434316e-01 | 0.843 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.528563e-01 | 0.816 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.528563e-01 | 0.816 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.621778e-01 | 0.790 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.621778e-01 | 0.790 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.621778e-01 | 0.790 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.621778e-01 | 0.790 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.621778e-01 | 0.790 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.621778e-01 | 0.790 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.621778e-01 | 0.790 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.621778e-01 | 0.790 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.713974e-01 | 0.766 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.895349e-01 | 0.722 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.895349e-01 | 0.722 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.895349e-01 | 0.722 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.895349e-01 | 0.722 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.895349e-01 | 0.722 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.984550e-01 | 0.702 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.072776e-01 | 0.683 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.072776e-01 | 0.683 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.246340e-01 | 0.649 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.429141e-01 | 0.845 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.467039e-01 | 0.834 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 2.055478e-01 | 0.687 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.135964e-01 | 0.670 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.645893e-01 | 0.784 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.645893e-01 | 0.784 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.737600e-01 | 0.760 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.616195e-01 | 0.792 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.737600e-01 | 0.760 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.528563e-01 | 0.816 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.621778e-01 | 0.790 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 1.242683e-01 | 0.906 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.243071e-01 | 0.906 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 1.145274e-01 | 0.941 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.155185e-01 | 0.667 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.160035e-01 | 0.666 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 1.145274e-01 | 0.941 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.339027e-01 | 0.873 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.339027e-01 | 0.873 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.434316e-01 | 0.843 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 1.434316e-01 | 0.843 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.434316e-01 | 0.843 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 1.528563e-01 | 0.816 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.528563e-01 | 0.816 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.528563e-01 | 0.816 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.621778e-01 | 0.790 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.895349e-01 | 0.722 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 1.984550e-01 | 0.702 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.095681e-01 | 0.679 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.429141e-01 | 0.845 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.543444e-01 | 0.812 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.242683e-01 | 0.906 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.805160e-01 | 0.743 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 1.984550e-01 | 0.702 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 2.160035e-01 | 0.666 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 2.160035e-01 | 0.666 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.713974e-01 | 0.766 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.242683e-01 | 0.906 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 1.528563e-01 | 0.816 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 1.621778e-01 | 0.790 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.895349e-01 | 0.722 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 2.246340e-01 | 0.649 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 2.246340e-01 | 0.649 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 2.176321e-01 | 0.662 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.467039e-01 | 0.834 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 1.816345e-01 | 0.741 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 1.805160e-01 | 0.743 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.805160e-01 | 0.743 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.145274e-01 | 0.941 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.242683e-01 | 0.906 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.339027e-01 | 0.873 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.621778e-01 | 0.790 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.621778e-01 | 0.790 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.621778e-01 | 0.790 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.984550e-01 | 0.702 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.722398e-01 | 0.764 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.242683e-01 | 0.906 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.895349e-01 | 0.722 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.026708e-01 | 0.693 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.246340e-01 | 0.649 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.434316e-01 | 0.843 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 1.434316e-01 | 0.843 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.713974e-01 | 0.766 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.895349e-01 | 0.722 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.160035e-01 | 0.666 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.928323e-01 | 0.715 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.973079e-01 | 0.705 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.749501e-01 | 0.757 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.246340e-01 | 0.649 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.246340e-01 | 0.649 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.434316e-01 | 0.843 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.805160e-01 | 0.743 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.581933e-01 | 0.801 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 1.984550e-01 | 0.702 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.246340e-01 | 0.649 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.536273e-01 | 0.814 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 1.984550e-01 | 0.702 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.536273e-01 | 0.814 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.656077e-01 | 0.781 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.072776e-01 | 0.683 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 1.432982e-01 | 0.844 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.776903e-01 | 0.750 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.135964e-01 | 0.670 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.185865e-01 | 0.926 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 2.246340e-01 | 0.649 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.434979e-01 | 0.843 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.072776e-01 | 0.683 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.984550e-01 | 0.702 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.984550e-01 | 0.702 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.160035e-01 | 0.666 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.160035e-01 | 0.666 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.434316e-01 | 0.843 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.458582e-01 | 0.836 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.458582e-01 | 0.836 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 2.015363e-01 | 0.696 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.279797e-01 | 0.893 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.257232e-01 | 0.646 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.297773e-01 | 0.639 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.331699e-01 | 0.632 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.331699e-01 | 0.632 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.331699e-01 | 0.632 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 2.331699e-01 | 0.632 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.331699e-01 | 0.632 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 2.331699e-01 | 0.632 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.331699e-01 | 0.632 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.331699e-01 | 0.632 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.338364e-01 | 0.631 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.371396e-01 | 0.625 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.400738e-01 | 0.620 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.416125e-01 | 0.617 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.416125e-01 | 0.617 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.416125e-01 | 0.617 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 2.416125e-01 | 0.617 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.416125e-01 | 0.617 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.460370e-01 | 0.609 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.499625e-01 | 0.602 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.499625e-01 | 0.602 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 2.499625e-01 | 0.602 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.499625e-01 | 0.602 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.499625e-01 | 0.602 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.499625e-01 | 0.602 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.499625e-01 | 0.602 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.518162e-01 | 0.599 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.518162e-01 | 0.599 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.518162e-01 | 0.599 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.541848e-01 | 0.595 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.547654e-01 | 0.594 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.582212e-01 | 0.588 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.582212e-01 | 0.588 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 2.582212e-01 | 0.588 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.582212e-01 | 0.588 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.663894e-01 | 0.574 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.663894e-01 | 0.574 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.663894e-01 | 0.574 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.663894e-01 | 0.574 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 2.663894e-01 | 0.574 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.663894e-01 | 0.574 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.663894e-01 | 0.574 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.663894e-01 | 0.574 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.663894e-01 | 0.574 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 2.663894e-01 | 0.574 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.663894e-01 | 0.574 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.704945e-01 | 0.568 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.704945e-01 | 0.568 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.744682e-01 | 0.562 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.744682e-01 | 0.562 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.744682e-01 | 0.562 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 2.744682e-01 | 0.562 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.785186e-01 | 0.555 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.824585e-01 | 0.549 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.824585e-01 | 0.549 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.824585e-01 | 0.549 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.827234e-01 | 0.549 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.844932e-01 | 0.546 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.867964e-01 | 0.542 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.896710e-01 | 0.538 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.903613e-01 | 0.537 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 2.903613e-01 | 0.537 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.903613e-01 | 0.537 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 2.903613e-01 | 0.537 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 2.904788e-01 | 0.537 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 2.925702e-01 | 0.534 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.964737e-01 | 0.528 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.981776e-01 | 0.526 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.981776e-01 | 0.526 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.981776e-01 | 0.526 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.030609e-01 | 0.518 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.059082e-01 | 0.514 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.059082e-01 | 0.514 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 3.059082e-01 | 0.514 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.059082e-01 | 0.514 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 3.059082e-01 | 0.514 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.059082e-01 | 0.514 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 3.059082e-01 | 0.514 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 3.059082e-01 | 0.514 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 3.059082e-01 | 0.514 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.071179e-01 | 0.513 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.111705e-01 | 0.507 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.135541e-01 | 0.504 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.135541e-01 | 0.504 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 3.135541e-01 | 0.504 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.135541e-01 | 0.504 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.144985e-01 | 0.502 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.211163e-01 | 0.493 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.211163e-01 | 0.493 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 3.211163e-01 | 0.493 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.211163e-01 | 0.493 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.211163e-01 | 0.493 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.211163e-01 | 0.493 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.211163e-01 | 0.493 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.285957e-01 | 0.483 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.285957e-01 | 0.483 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.285957e-01 | 0.483 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.285957e-01 | 0.483 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.285957e-01 | 0.483 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.313532e-01 | 0.480 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.313532e-01 | 0.480 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.353712e-01 | 0.474 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.359931e-01 | 0.474 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.359931e-01 | 0.474 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 3.359931e-01 | 0.474 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.393822e-01 | 0.469 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.393822e-01 | 0.469 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.393822e-01 | 0.469 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.433094e-01 | 0.464 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.433094e-01 | 0.464 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.433094e-01 | 0.464 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.433858e-01 | 0.464 | 0 | 0 |
| Disease | R-HSA-1643685 | 3.441907e-01 | 0.463 | 1 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.505456e-01 | 0.455 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.505456e-01 | 0.455 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 3.505456e-01 | 0.455 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.505456e-01 | 0.455 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.553496e-01 | 0.449 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.577025e-01 | 0.446 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 3.577025e-01 | 0.446 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.577025e-01 | 0.446 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.595913e-01 | 0.444 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.632831e-01 | 0.440 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.647810e-01 | 0.438 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 3.647810e-01 | 0.438 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.647810e-01 | 0.438 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 3.647810e-01 | 0.438 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.711799e-01 | 0.430 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.717819e-01 | 0.430 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.717819e-01 | 0.430 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.717819e-01 | 0.430 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 3.717819e-01 | 0.430 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.751139e-01 | 0.426 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.787060e-01 | 0.422 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.787060e-01 | 0.422 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 3.787060e-01 | 0.422 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.829518e-01 | 0.417 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.829518e-01 | 0.417 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 3.855543e-01 | 0.414 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.868552e-01 | 0.412 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.907479e-01 | 0.408 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.985001e-01 | 0.400 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.985001e-01 | 0.400 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.990264e-01 | 0.399 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.990264e-01 | 0.399 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.990264e-01 | 0.399 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.990264e-01 | 0.399 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.023592e-01 | 0.395 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.056519e-01 | 0.392 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.056519e-01 | 0.392 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 4.056519e-01 | 0.392 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.056519e-01 | 0.392 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.056519e-01 | 0.392 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.101594e-01 | 0.387 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.122048e-01 | 0.385 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.122048e-01 | 0.385 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.122048e-01 | 0.385 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.138661e-01 | 0.383 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.186858e-01 | 0.378 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.250958e-01 | 0.372 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.314355e-01 | 0.365 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.327970e-01 | 0.364 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.327970e-01 | 0.364 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.364627e-01 | 0.360 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.365445e-01 | 0.360 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 4.377056e-01 | 0.359 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.377056e-01 | 0.359 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.377056e-01 | 0.359 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.377056e-01 | 0.359 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.377056e-01 | 0.359 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.439993e-01 | 0.353 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.439993e-01 | 0.353 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.477064e-01 | 0.349 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.500404e-01 | 0.347 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.500404e-01 | 0.347 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.534894e-01 | 0.343 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.558634e-01 | 0.341 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.561065e-01 | 0.341 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.561065e-01 | 0.341 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.621061e-01 | 0.335 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.621061e-01 | 0.335 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.680399e-01 | 0.330 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.736561e-01 | 0.325 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.739085e-01 | 0.324 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 4.739085e-01 | 0.324 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.739085e-01 | 0.324 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.854534e-01 | 0.314 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.854534e-01 | 0.314 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 4.854534e-01 | 0.314 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 4.854534e-01 | 0.314 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.875446e-01 | 0.312 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.911310e-01 | 0.309 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 4.911310e-01 | 0.309 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.967463e-01 | 0.304 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.077927e-01 | 0.294 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 5.077927e-01 | 0.294 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.077927e-01 | 0.294 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 5.085128e-01 | 0.294 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.132252e-01 | 0.290 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.132252e-01 | 0.290 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.153778e-01 | 0.288 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.239119e-01 | 0.281 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.239119e-01 | 0.281 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.239119e-01 | 0.281 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.239119e-01 | 0.281 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.239119e-01 | 0.281 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.239119e-01 | 0.281 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 5.283350e-01 | 0.277 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.289176e-01 | 0.277 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.291674e-01 | 0.276 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 5.291674e-01 | 0.276 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.322625e-01 | 0.274 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.339561e-01 | 0.272 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.343653e-01 | 0.272 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 5.343653e-01 | 0.272 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.395060e-01 | 0.268 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.395060e-01 | 0.268 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.395060e-01 | 0.268 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.445904e-01 | 0.264 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.445904e-01 | 0.264 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 5.445904e-01 | 0.264 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 5.446719e-01 | 0.264 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.454807e-01 | 0.263 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.496189e-01 | 0.260 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 5.496189e-01 | 0.260 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.519922e-01 | 0.258 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.545922e-01 | 0.256 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.595109e-01 | 0.252 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 5.616364e-01 | 0.251 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 5.643755e-01 | 0.248 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.643755e-01 | 0.248 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.648183e-01 | 0.248 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.679836e-01 | 0.246 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.691868e-01 | 0.245 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.691868e-01 | 0.245 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.691868e-01 | 0.245 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.742647e-01 | 0.241 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.786513e-01 | 0.238 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.786513e-01 | 0.238 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 5.786513e-01 | 0.238 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.833057e-01 | 0.234 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.833057e-01 | 0.234 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 5.833057e-01 | 0.234 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 5.835621e-01 | 0.234 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.866281e-01 | 0.232 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.879091e-01 | 0.231 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.879091e-01 | 0.231 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.924618e-01 | 0.227 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.924618e-01 | 0.227 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.924618e-01 | 0.227 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.969645e-01 | 0.224 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.969645e-01 | 0.224 | 1 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.014178e-01 | 0.221 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.014178e-01 | 0.221 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.014178e-01 | 0.221 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.014178e-01 | 0.221 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 6.144860e-01 | 0.211 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.144860e-01 | 0.211 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 6.144860e-01 | 0.211 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.229606e-01 | 0.206 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.229606e-01 | 0.206 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 6.271282e-01 | 0.203 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 6.271282e-01 | 0.203 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 6.276291e-01 | 0.202 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.312499e-01 | 0.200 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.312499e-01 | 0.200 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.334235e-01 | 0.198 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.433453e-01 | 0.192 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.472888e-01 | 0.189 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.472888e-01 | 0.189 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 6.484961e-01 | 0.188 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 6.484961e-01 | 0.188 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.511889e-01 | 0.186 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 6.550724e-01 | 0.184 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 6.578874e-01 | 0.182 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.588609e-01 | 0.181 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.588609e-01 | 0.181 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.663651e-01 | 0.176 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.700554e-01 | 0.174 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.700554e-01 | 0.174 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.709085e-01 | 0.173 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.735351e-01 | 0.172 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.737051e-01 | 0.172 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.773147e-01 | 0.169 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 6.808846e-01 | 0.167 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.808846e-01 | 0.167 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.808846e-01 | 0.167 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.810360e-01 | 0.167 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 6.810768e-01 | 0.167 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 6.844152e-01 | 0.165 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 6.947756e-01 | 0.158 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.014939e-01 | 0.154 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.028976e-01 | 0.153 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 7.047977e-01 | 0.152 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.052487e-01 | 0.152 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.080652e-01 | 0.150 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 7.080652e-01 | 0.150 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.112967e-01 | 0.148 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.112967e-01 | 0.148 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.144926e-01 | 0.146 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.207792e-01 | 0.142 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.279205e-01 | 0.138 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.328465e-01 | 0.135 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.329426e-01 | 0.135 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 7.365700e-01 | 0.133 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.386956e-01 | 0.132 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.388252e-01 | 0.131 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.388252e-01 | 0.131 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 7.417179e-01 | 0.130 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 7.445789e-01 | 0.128 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 7.474083e-01 | 0.126 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.502065e-01 | 0.125 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 7.526280e-01 | 0.123 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.557109e-01 | 0.122 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.584177e-01 | 0.120 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.591617e-01 | 0.120 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.610946e-01 | 0.119 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.610946e-01 | 0.119 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.610946e-01 | 0.119 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.611306e-01 | 0.119 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.663604e-01 | 0.116 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.715107e-01 | 0.113 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 7.765481e-01 | 0.110 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.765481e-01 | 0.110 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.782347e-01 | 0.109 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 7.782347e-01 | 0.109 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.802284e-01 | 0.108 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.838978e-01 | 0.106 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.886636e-01 | 0.103 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.910072e-01 | 0.102 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.933249e-01 | 0.101 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.976526e-01 | 0.098 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 8.067040e-01 | 0.093 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.088486e-01 | 0.092 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.108719e-01 | 0.091 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.171928e-01 | 0.088 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.171928e-01 | 0.088 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.212281e-01 | 0.086 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.232124e-01 | 0.084 | 0 | 0 |
| M Phase | R-HSA-68886 | 8.248345e-01 | 0.084 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.271155e-01 | 0.082 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.309329e-01 | 0.080 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 8.328101e-01 | 0.079 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.346665e-01 | 0.078 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 8.348081e-01 | 0.078 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.383181e-01 | 0.077 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.394079e-01 | 0.076 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.401137e-01 | 0.076 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.418895e-01 | 0.075 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.477916e-01 | 0.072 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.487986e-01 | 0.071 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.504784e-01 | 0.070 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.504784e-01 | 0.070 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.537826e-01 | 0.069 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 8.543989e-01 | 0.068 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.570142e-01 | 0.067 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.570142e-01 | 0.067 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.570142e-01 | 0.067 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.586033e-01 | 0.066 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.586033e-01 | 0.066 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.677755e-01 | 0.062 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.683093e-01 | 0.061 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 8.697707e-01 | 0.061 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 8.721373e-01 | 0.059 | 0 | 0 |
| Translation | R-HSA-72766 | 8.767384e-01 | 0.057 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.817662e-01 | 0.055 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.817662e-01 | 0.055 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.881992e-01 | 0.051 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.906738e-01 | 0.050 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.933690e-01 | 0.049 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.939441e-01 | 0.049 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.942840e-01 | 0.049 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.000056e-01 | 0.046 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.022533e-01 | 0.045 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.068186e-01 | 0.042 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.086068e-01 | 0.042 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 9.088025e-01 | 0.042 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.112117e-01 | 0.040 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.126125e-01 | 0.040 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.155018e-01 | 0.038 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.164725e-01 | 0.038 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.409904e-01 | 0.026 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.448365e-01 | 0.025 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.501431e-01 | 0.022 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.507005e-01 | 0.022 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 9.549419e-01 | 0.020 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.578830e-01 | 0.019 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.579052e-01 | 0.019 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.597368e-01 | 0.018 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.598460e-01 | 0.018 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.640241e-01 | 0.016 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.656090e-01 | 0.015 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.702958e-01 | 0.013 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.775968e-01 | 0.010 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.777884e-01 | 0.010 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.785863e-01 | 0.009 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.823293e-01 | 0.008 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.857474e-01 | 0.006 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.863785e-01 | 0.006 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.888412e-01 | 0.005 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.891406e-01 | 0.005 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.917294e-01 | 0.004 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.952087e-01 | 0.002 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.977954e-01 | 0.001 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.992589e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.995728e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.996438e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.998557e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999936e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 1.000000e+00 | 0.000 | 1 | 1 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 1.000000e+00 | 0.000 | 1 | 0 |
| t(4;14) translocations of FGFR3 | R-HSA-2033515 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by FGFR3 fusions in cancer | R-HSA-8853334 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.110223e-16 | 15.955 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.440892e-16 | 15.353 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.965095e-14 | 13.707 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.462297e-14 | 13.263 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.462297e-14 | 13.263 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.025846e-13 | 12.989 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.471356e-13 | 12.607 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.261835e-13 | 12.487 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.902434e-13 | 12.409 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.237721e-13 | 12.373 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.559997e-13 | 12.255 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.559997e-13 | 12.255 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 7.133183e-13 | 12.147 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.232615e-13 | 12.035 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.043499e-12 | 11.982 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.043499e-12 | 11.982 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.179057e-12 | 11.928 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.179057e-12 | 11.928 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.497136e-12 | 11.825 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.725398e-12 | 11.763 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.375433e-12 | 11.624 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.375433e-12 | 11.624 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.603029e-12 | 11.585 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.969514e-12 | 11.527 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.969514e-12 | 11.527 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.575340e-12 | 11.340 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.575340e-12 | 11.340 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.641487e-12 | 11.249 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.992096e-12 | 11.222 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.608825e-12 | 11.180 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.470113e-12 | 11.072 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.470113e-12 | 11.072 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.078337e-11 | 10.967 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.513645e-11 | 10.820 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.620759e-11 | 10.582 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.303680e-11 | 10.481 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 3.126699e-11 | 10.505 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.350165e-11 | 10.475 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.401823e-11 | 10.468 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.718914e-11 | 10.430 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 4.410250e-11 | 10.356 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.215162e-11 | 10.283 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 8.484080e-11 | 10.071 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 9.926848e-11 | 10.003 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.158653e-10 | 9.936 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.567355e-10 | 9.805 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.567355e-10 | 9.805 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.793221e-10 | 9.554 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.210682e-10 | 9.493 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.336411e-10 | 9.477 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.683323e-10 | 9.434 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.820199e-10 | 9.317 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.820199e-10 | 9.317 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.499071e-10 | 9.260 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 6.262507e-10 | 9.203 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.653424e-10 | 9.177 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.035855e-09 | 8.985 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.105451e-09 | 8.956 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.161210e-09 | 8.935 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.161210e-09 | 8.935 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.161210e-09 | 8.935 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.353498e-09 | 8.869 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.319606e-09 | 8.880 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.671111e-09 | 8.777 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.822962e-09 | 8.739 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.822962e-09 | 8.739 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.876521e-09 | 8.727 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.876521e-09 | 8.727 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.104255e-09 | 8.677 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.635310e-09 | 8.579 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.943374e-09 | 8.531 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.225382e-09 | 8.491 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.716725e-09 | 8.430 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.285173e-09 | 8.277 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.568338e-09 | 8.254 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.167458e-09 | 8.210 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.325665e-09 | 8.080 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.344963e-08 | 7.871 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.760782e-08 | 7.559 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.760782e-08 | 7.559 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.211873e-08 | 7.376 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.541727e-08 | 7.256 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.825332e-08 | 7.235 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.306018e-08 | 7.200 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.423660e-08 | 7.129 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 8.451408e-08 | 7.073 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 8.857390e-08 | 7.053 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.000473e-07 | 7.000 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.249312e-07 | 6.903 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.409284e-07 | 6.851 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.444322e-07 | 6.840 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.617646e-07 | 6.791 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.787533e-07 | 6.748 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.787533e-07 | 6.748 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.787533e-07 | 6.748 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.819920e-07 | 6.740 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.697391e-07 | 6.569 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.422761e-07 | 6.466 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.104320e-07 | 6.508 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.219090e-07 | 6.492 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.187143e-07 | 6.497 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.159564e-07 | 6.287 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.447430e-07 | 6.264 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.389854e-07 | 6.195 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.389854e-07 | 6.195 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.887428e-07 | 6.162 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.895229e-07 | 6.103 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 8.680246e-07 | 6.061 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 9.213780e-07 | 6.036 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.245310e-06 | 5.905 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.316752e-06 | 5.880 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.688466e-06 | 5.773 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.746724e-06 | 5.758 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.018725e-06 | 5.695 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.018725e-06 | 5.695 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.018725e-06 | 5.695 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.142575e-06 | 5.669 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.063457e-06 | 5.514 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.067676e-06 | 5.513 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.954360e-06 | 5.403 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 4.039968e-06 | 5.394 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.271173e-06 | 5.369 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.371851e-06 | 5.359 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.863492e-06 | 5.232 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.259407e-06 | 5.203 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.249172e-06 | 5.140 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.352618e-06 | 5.134 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 8.231597e-06 | 5.085 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.315864e-06 | 5.031 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.066347e-05 | 4.972 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.696091e-05 | 4.771 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.877591e-05 | 4.541 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.547133e-05 | 4.450 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.635996e-05 | 4.439 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.190063e-05 | 4.378 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.445060e-05 | 4.128 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.286629e-05 | 4.082 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.578096e-05 | 4.120 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 7.275383e-05 | 4.138 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 8.348627e-05 | 4.078 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 8.139528e-05 | 4.089 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 6.929161e-05 | 4.159 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.088759e-05 | 4.092 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 8.684909e-05 | 4.061 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.462854e-05 | 4.024 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.364734e-04 | 3.865 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.364734e-04 | 3.865 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.433091e-04 | 3.844 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 1.437227e-04 | 3.842 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.437227e-04 | 3.842 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.501930e-04 | 3.823 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.627592e-04 | 3.788 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.899252e-04 | 3.721 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.899252e-04 | 3.721 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.011373e-04 | 3.697 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.133074e-04 | 3.671 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.133074e-04 | 3.671 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.133074e-04 | 3.671 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.133074e-04 | 3.671 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.149757e-04 | 3.668 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.307635e-04 | 3.637 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.475032e-04 | 3.606 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.147828e-04 | 3.502 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.405645e-04 | 3.468 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.071605e-04 | 3.390 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.085159e-04 | 3.389 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.124221e-04 | 3.385 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.222316e-04 | 3.374 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 4.272784e-04 | 3.369 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.452068e-04 | 3.351 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.239207e-04 | 3.281 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.471360e-04 | 3.262 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 5.955017e-04 | 3.225 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 8.300265e-04 | 3.081 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.888877e-04 | 3.051 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.157859e-03 | 2.936 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.070211e-03 | 2.971 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 9.241627e-04 | 3.034 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.230071e-03 | 2.910 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.175651e-03 | 2.930 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.269036e-03 | 2.897 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.471280e-03 | 2.832 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.593112e-03 | 2.798 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.797189e-03 | 2.745 | 0 | 0 |
| Disease | R-HSA-1643685 | 2.024860e-03 | 2.694 | 1 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.383474e-03 | 2.623 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 2.389503e-03 | 2.622 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.619501e-03 | 2.582 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 2.907521e-03 | 2.536 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.381695e-03 | 2.358 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 4.485097e-03 | 2.348 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.835716e-03 | 2.316 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 4.942624e-03 | 2.306 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.251338e-03 | 2.280 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 5.392311e-03 | 2.268 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.392311e-03 | 2.268 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.376347e-03 | 2.195 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 6.376347e-03 | 2.195 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 6.376347e-03 | 2.195 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.376347e-03 | 2.195 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.424932e-03 | 2.129 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.435638e-03 | 2.129 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 7.939368e-03 | 2.100 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 8.312556e-03 | 2.080 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.474334e-03 | 2.072 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 9.030002e-03 | 2.044 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.261239e-03 | 2.033 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 9.764159e-03 | 2.010 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 9.764159e-03 | 2.010 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 9.764159e-03 | 2.010 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 9.764159e-03 | 2.010 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 9.764159e-03 | 2.010 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 9.764159e-03 | 2.010 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 9.773830e-03 | 2.010 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.082279e-02 | 1.966 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.098712e-02 | 1.959 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.104971e-02 | 1.957 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.146278e-02 | 1.941 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.239480e-02 | 1.907 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.239480e-02 | 1.907 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.245841e-02 | 1.905 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.280709e-02 | 1.893 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.281056e-02 | 1.892 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.010824e-02 | 1.697 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.010824e-02 | 1.697 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.654758e-02 | 1.781 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.736137e-02 | 1.760 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.864845e-02 | 1.729 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.736137e-02 | 1.760 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.683090e-02 | 1.774 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.760705e-02 | 1.754 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.498588e-02 | 1.824 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.010824e-02 | 1.697 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.999122e-02 | 1.699 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.083712e-02 | 1.681 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 2.176134e-02 | 1.662 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.183878e-02 | 1.661 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.183878e-02 | 1.661 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 2.322709e-02 | 1.634 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.367620e-02 | 1.626 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.377265e-02 | 1.624 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.446734e-02 | 1.611 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.459812e-02 | 1.609 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.547694e-02 | 1.594 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.567958e-02 | 1.590 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.567958e-02 | 1.590 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.572010e-02 | 1.590 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.589335e-02 | 1.587 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.610134e-02 | 1.583 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.671443e-02 | 1.573 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.738197e-02 | 1.563 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.738197e-02 | 1.563 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.738197e-02 | 1.563 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 2.777136e-02 | 1.556 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.819608e-02 | 1.550 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.880967e-02 | 1.540 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.934258e-02 | 1.533 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.127259e-02 | 1.505 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.135754e-02 | 1.504 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.135754e-02 | 1.504 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.285283e-02 | 1.483 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.426858e-02 | 1.465 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.724568e-02 | 1.429 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.771620e-02 | 1.423 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.771620e-02 | 1.423 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.771620e-02 | 1.423 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.849183e-02 | 1.415 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 3.849183e-02 | 1.415 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.849183e-02 | 1.415 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 3.849183e-02 | 1.415 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 3.849183e-02 | 1.415 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.849183e-02 | 1.415 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.849183e-02 | 1.415 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.849183e-02 | 1.415 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.849183e-02 | 1.415 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.849183e-02 | 1.415 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.849183e-02 | 1.415 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.849183e-02 | 1.415 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.849183e-02 | 1.415 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.849183e-02 | 1.415 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.849183e-02 | 1.415 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 3.946304e-02 | 1.404 | 1 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.954442e-02 | 1.403 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.993636e-02 | 1.399 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.001831e-02 | 1.398 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.096203e-02 | 1.388 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 4.191836e-02 | 1.378 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.220488e-02 | 1.375 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.220488e-02 | 1.375 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.623785e-02 | 1.335 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.688243e-02 | 1.329 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.688883e-02 | 1.329 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.763965e-02 | 1.322 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.788247e-02 | 1.320 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.788247e-02 | 1.320 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.788247e-02 | 1.320 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 4.788247e-02 | 1.320 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.788247e-02 | 1.320 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.928923e-02 | 1.307 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.718197e-02 | 1.243 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.639121e-02 | 1.178 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 6.639121e-02 | 1.178 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 7.551106e-02 | 1.122 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 8.454239e-02 | 1.073 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 8.454239e-02 | 1.073 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 9.348603e-02 | 1.029 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 9.348603e-02 | 1.029 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 9.348603e-02 | 1.029 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 9.348603e-02 | 1.029 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.173992e-02 | 1.286 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.987924e-02 | 1.223 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.196031e-02 | 1.208 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 8.712582e-02 | 1.060 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.089922e-02 | 1.149 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 7.551106e-02 | 1.122 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.279989e-02 | 1.138 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 5.173992e-02 | 1.286 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.639121e-02 | 1.178 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 7.551106e-02 | 1.122 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.350041e-02 | 1.078 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.461465e-02 | 1.190 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.326778e-02 | 1.274 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.350041e-02 | 1.078 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.519618e-02 | 1.070 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.718197e-02 | 1.243 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 7.551106e-02 | 1.122 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.141345e-02 | 1.212 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 9.918643e-02 | 1.004 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 8.454239e-02 | 1.073 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 7.106458e-02 | 1.148 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.648258e-02 | 1.248 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 7.551106e-02 | 1.122 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 8.454239e-02 | 1.073 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 9.348603e-02 | 1.029 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.307436e-02 | 1.031 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.549405e-02 | 1.256 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.289493e-02 | 1.032 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 5.495793e-02 | 1.260 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.676868e-02 | 1.246 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.279989e-02 | 1.138 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.056022e-02 | 1.296 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 9.307436e-02 | 1.031 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.609190e-02 | 1.017 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 7.092653e-02 | 1.149 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.423342e-02 | 1.266 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.730668e-02 | 1.172 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.008538e-02 | 1.045 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.375876e-02 | 1.132 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.196031e-02 | 1.208 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 9.030142e-02 | 1.044 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.237233e-02 | 1.140 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.559917e-02 | 1.121 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.023429e-01 | 0.990 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.023429e-01 | 0.990 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.023429e-01 | 0.990 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.023429e-01 | 0.990 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.067406e-01 | 0.972 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.084313e-01 | 0.965 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.111137e-01 | 0.954 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 1.111137e-01 | 0.954 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.111137e-01 | 0.954 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.111137e-01 | 0.954 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.149941e-01 | 0.939 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.149941e-01 | 0.939 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.179463e-01 | 0.928 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.197994e-01 | 0.922 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.197994e-01 | 0.922 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.197994e-01 | 0.922 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.197994e-01 | 0.922 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.197994e-01 | 0.922 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.197994e-01 | 0.922 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.284007e-01 | 0.891 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.284007e-01 | 0.891 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.284007e-01 | 0.891 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.309412e-01 | 0.883 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.342403e-01 | 0.872 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.366219e-01 | 0.864 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.366219e-01 | 0.864 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.369185e-01 | 0.864 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.369185e-01 | 0.864 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.369189e-01 | 0.864 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 1.388575e-01 | 0.857 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.442469e-01 | 0.841 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.453536e-01 | 0.838 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.453536e-01 | 0.838 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.453536e-01 | 0.838 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.453536e-01 | 0.838 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.453536e-01 | 0.838 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.453536e-01 | 0.838 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.476168e-01 | 0.831 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.476168e-01 | 0.831 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.510028e-01 | 0.821 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.537067e-01 | 0.813 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.537067e-01 | 0.813 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.546286e-01 | 0.811 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.578206e-01 | 0.802 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.578206e-01 | 0.802 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.612511e-01 | 0.792 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.619788e-01 | 0.791 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.619788e-01 | 0.791 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.619788e-01 | 0.791 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.619788e-01 | 0.791 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.619788e-01 | 0.791 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.642298e-01 | 0.785 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.701704e-01 | 0.769 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.701704e-01 | 0.769 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.701704e-01 | 0.769 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 1.701704e-01 | 0.769 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.701704e-01 | 0.769 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.701704e-01 | 0.769 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.701704e-01 | 0.769 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 1.701704e-01 | 0.769 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.701704e-01 | 0.769 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.716222e-01 | 0.765 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.716222e-01 | 0.765 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.720756e-01 | 0.764 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.751037e-01 | 0.757 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.782826e-01 | 0.749 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.782826e-01 | 0.749 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.810443e-01 | 0.742 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.856144e-01 | 0.731 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 1.856144e-01 | 0.731 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 1.863159e-01 | 0.730 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.863159e-01 | 0.730 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 1.863159e-01 | 0.730 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.913351e-01 | 0.718 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.942711e-01 | 0.712 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.942711e-01 | 0.712 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.942711e-01 | 0.712 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.986391e-01 | 0.702 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.007990e-01 | 0.697 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.007990e-01 | 0.697 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.007990e-01 | 0.697 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.021491e-01 | 0.694 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.021491e-01 | 0.694 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.021491e-01 | 0.694 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.068847e-01 | 0.684 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.099505e-01 | 0.678 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.099505e-01 | 0.678 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.099505e-01 | 0.678 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 2.099505e-01 | 0.678 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 2.099505e-01 | 0.678 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.099505e-01 | 0.678 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.108635e-01 | 0.676 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.140339e-01 | 0.670 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.140339e-01 | 0.670 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.140339e-01 | 0.670 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.176174e-01 | 0.662 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.176762e-01 | 0.662 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.176762e-01 | 0.662 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.176762e-01 | 0.662 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.176762e-01 | 0.662 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.176762e-01 | 0.662 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.176762e-01 | 0.662 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.176762e-01 | 0.662 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.253267e-01 | 0.647 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.253267e-01 | 0.647 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.329029e-01 | 0.633 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.392160e-01 | 0.621 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 2.404055e-01 | 0.619 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.404055e-01 | 0.619 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 2.404055e-01 | 0.619 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.404055e-01 | 0.619 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.442699e-01 | 0.612 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.464425e-01 | 0.608 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.478352e-01 | 0.606 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 2.478352e-01 | 0.606 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.478352e-01 | 0.606 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.478352e-01 | 0.606 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.478352e-01 | 0.606 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.478352e-01 | 0.606 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.551926e-01 | 0.593 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.551926e-01 | 0.593 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.551926e-01 | 0.593 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 2.551926e-01 | 0.593 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.551926e-01 | 0.593 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.551926e-01 | 0.593 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.624785e-01 | 0.581 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 2.624785e-01 | 0.581 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 2.624785e-01 | 0.581 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.624785e-01 | 0.581 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 2.645378e-01 | 0.578 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.645378e-01 | 0.578 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.696936e-01 | 0.569 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 2.696936e-01 | 0.569 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 2.754003e-01 | 0.560 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.768386e-01 | 0.558 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.768386e-01 | 0.558 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 2.768386e-01 | 0.558 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.768386e-01 | 0.558 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.768386e-01 | 0.558 | 1 | 1 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.768386e-01 | 0.558 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 2.790200e-01 | 0.554 | 0 | 0 |
| Translation | R-HSA-72766 | 2.812538e-01 | 0.551 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.834032e-01 | 0.548 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 2.837607e-01 | 0.547 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.839141e-01 | 0.547 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.839141e-01 | 0.547 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 2.839141e-01 | 0.547 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 2.839141e-01 | 0.547 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.862555e-01 | 0.543 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 2.909208e-01 | 0.536 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 2.909208e-01 | 0.536 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 2.978593e-01 | 0.526 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.978593e-01 | 0.526 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 2.978593e-01 | 0.526 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.007026e-01 | 0.522 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.047304e-01 | 0.516 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.047304e-01 | 0.516 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.047304e-01 | 0.516 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 3.047304e-01 | 0.516 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.047304e-01 | 0.516 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.115077e-01 | 0.507 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.115077e-01 | 0.507 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.115347e-01 | 0.506 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 3.182728e-01 | 0.497 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.182728e-01 | 0.497 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.182728e-01 | 0.497 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.182728e-01 | 0.497 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.249454e-01 | 0.488 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 3.315531e-01 | 0.479 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.317781e-01 | 0.479 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.380965e-01 | 0.471 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.380965e-01 | 0.471 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.380965e-01 | 0.471 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.380965e-01 | 0.471 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 3.380965e-01 | 0.471 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 3.422149e-01 | 0.466 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 3.422149e-01 | 0.466 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.445762e-01 | 0.463 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 3.480886e-01 | 0.458 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.507804e-01 | 0.455 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.509929e-01 | 0.455 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.509929e-01 | 0.455 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 3.573472e-01 | 0.447 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 3.573472e-01 | 0.447 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.636397e-01 | 0.439 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.636397e-01 | 0.439 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.636397e-01 | 0.439 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 3.636397e-01 | 0.439 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.698709e-01 | 0.432 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.698709e-01 | 0.432 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.698709e-01 | 0.432 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.698709e-01 | 0.432 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.698709e-01 | 0.432 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.698709e-01 | 0.432 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.698709e-01 | 0.432 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 3.698709e-01 | 0.432 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.760415e-01 | 0.425 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.760415e-01 | 0.425 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 3.776166e-01 | 0.423 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.821521e-01 | 0.418 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 3.823470e-01 | 0.418 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 3.823470e-01 | 0.418 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.823470e-01 | 0.418 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.882032e-01 | 0.411 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.882032e-01 | 0.411 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 3.928930e-01 | 0.406 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.941954e-01 | 0.404 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 3.941954e-01 | 0.404 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.996058e-01 | 0.398 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.060054e-01 | 0.391 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.060054e-01 | 0.391 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.060054e-01 | 0.391 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.087065e-01 | 0.389 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.113224e-01 | 0.386 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.118243e-01 | 0.385 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.118243e-01 | 0.385 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.118243e-01 | 0.385 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.118243e-01 | 0.385 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.232927e-01 | 0.373 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.289433e-01 | 0.368 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.289433e-01 | 0.368 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.289433e-01 | 0.368 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.345389e-01 | 0.362 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.345389e-01 | 0.362 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.372754e-01 | 0.359 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 4.400801e-01 | 0.356 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 4.424167e-01 | 0.354 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.455672e-01 | 0.351 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.455672e-01 | 0.351 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 4.500950e-01 | 0.347 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.510009e-01 | 0.346 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.510009e-01 | 0.346 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.510009e-01 | 0.346 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.563817e-01 | 0.341 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.617101e-01 | 0.336 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.662185e-01 | 0.331 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.669866e-01 | 0.331 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.669866e-01 | 0.331 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.669866e-01 | 0.331 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.722117e-01 | 0.326 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.790205e-01 | 0.320 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 4.875835e-01 | 0.312 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.884992e-01 | 0.311 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 4.916350e-01 | 0.308 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.947588e-01 | 0.306 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.975834e-01 | 0.303 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.975834e-01 | 0.303 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 4.978705e-01 | 0.303 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.009700e-01 | 0.300 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 5.017800e-01 | 0.299 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.025104e-01 | 0.299 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.025104e-01 | 0.299 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.025104e-01 | 0.299 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.040574e-01 | 0.298 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.071325e-01 | 0.295 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.073894e-01 | 0.295 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.132457e-01 | 0.290 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.162837e-01 | 0.287 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.217429e-01 | 0.283 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 5.223223e-01 | 0.282 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.264344e-01 | 0.279 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 5.356807e-01 | 0.271 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.384395e-01 | 0.269 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.402363e-01 | 0.267 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.402363e-01 | 0.267 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.402363e-01 | 0.267 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 5.402363e-01 | 0.267 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 5.402363e-01 | 0.267 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.447476e-01 | 0.264 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.536385e-01 | 0.257 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.536385e-01 | 0.257 | 1 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.618781e-01 | 0.250 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.623568e-01 | 0.250 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.623568e-01 | 0.250 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.709060e-01 | 0.243 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.709060e-01 | 0.243 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.798985e-01 | 0.237 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 5.883517e-01 | 0.230 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.915597e-01 | 0.228 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.955703e-01 | 0.225 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.995418e-01 | 0.222 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.034746e-01 | 0.219 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.034746e-01 | 0.219 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.034746e-01 | 0.219 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.034746e-01 | 0.219 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.112253e-01 | 0.214 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.112253e-01 | 0.214 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.150440e-01 | 0.211 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.225700e-01 | 0.206 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.262779e-01 | 0.203 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.299497e-01 | 0.201 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 6.371861e-01 | 0.196 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.442818e-01 | 0.191 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 6.442818e-01 | 0.191 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.477777e-01 | 0.189 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.546676e-01 | 0.184 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.647520e-01 | 0.177 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.647520e-01 | 0.177 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.647520e-01 | 0.177 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.680481e-01 | 0.175 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.745438e-01 | 0.171 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 6.809707e-01 | 0.167 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.840514e-01 | 0.165 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 6.900385e-01 | 0.161 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.902359e-01 | 0.161 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.902359e-01 | 0.161 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.902359e-01 | 0.161 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 6.932829e-01 | 0.159 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 6.963001e-01 | 0.157 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.992878e-01 | 0.155 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.051759e-01 | 0.152 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.051759e-01 | 0.152 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 7.175870e-01 | 0.144 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.193997e-01 | 0.143 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.193997e-01 | 0.143 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.248963e-01 | 0.140 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.302860e-01 | 0.137 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.433055e-01 | 0.129 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.433055e-01 | 0.129 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.508154e-01 | 0.124 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.675003e-01 | 0.115 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.830745e-01 | 0.106 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 7.830745e-01 | 0.106 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.852131e-01 | 0.105 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.894276e-01 | 0.103 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.035416e-01 | 0.095 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.092988e-01 | 0.092 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.130435e-01 | 0.090 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.255837e-01 | 0.083 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.340257e-01 | 0.079 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.340257e-01 | 0.079 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.466963e-01 | 0.072 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.466963e-01 | 0.072 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.497108e-01 | 0.071 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.497108e-01 | 0.071 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.526663e-01 | 0.069 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.569917e-01 | 0.067 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.717992e-01 | 0.060 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 8.862196e-01 | 0.052 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.873459e-01 | 0.052 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.884611e-01 | 0.051 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 8.928133e-01 | 0.049 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.990271e-01 | 0.046 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.212897e-01 | 0.036 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.477294e-01 | 0.023 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.666874e-01 | 0.015 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.779269e-01 | 0.010 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.856834e-01 | 0.006 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.858251e-01 | 0.006 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.878150e-01 | 0.005 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.923446e-01 | 0.003 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.926987e-01 | 0.003 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.956164e-01 | 0.002 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.983344e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.995515e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.997289e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999969e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999982e-01 | 0.000 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 1.000000e+00 | 0.000 | 1 | 1 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 1.000000e+00 | 0.000 | 1 | 0 |
| t(4;14) translocations of FGFR3 | R-HSA-2033515 | 1.000000e+00 | 0.000 | 1 | 1 |
| Signaling by FGFR3 fusions in cancer | R-HSA-8853334 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
